-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TUhj/2hpZALP9D8a8nyIsp8c0hcQhld1+2vmVzLDzBNG7Ix7RZnz7mZr4A3miJPX sg6LYnEhUv/I5AzsSU1jHQ== 0000912057-00-005315.txt : 20000214 0000912057-00-005315.hdr.sgml : 20000214 ACCESSION NUMBER: 0000912057-00-005315 CONFORMED SUBMISSION TYPE: 10QSB PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 19991231 FILED AS OF DATE: 20000211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LEE PHARMACEUTICALS CENTRAL INDEX KEY: 0000058411 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 952680312 STATE OF INCORPORATION: CA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10QSB SEC ACT: SEC FILE NUMBER: 001-07335 FILM NUMBER: 532716 BUSINESS ADDRESS: STREET 1: 1444 SANTA ANITA AVE CITY: SOUTH EL MONTE STATE: CA ZIP: 91733 BUSINESS PHONE: 8184423141 MAIL ADDRESS: STREET 1: 1444 SANTA ANITA AVENUE STREET 2: 1444 SANTA ANITA AVENUE CITY: SOUTH EL MONTE STATE: CA ZIP: 91733 FORMER COMPANY: FORMER CONFORMED NAME: LEE INDUSTRIES INC DATE OF NAME CHANGE: 19720113 10QSB 1 10QSB SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 1999 ------------------------------------------- OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ------------------ ----------------- Commission file number 1-7335 -------------------------------------------------------- LEE PHARMACEUTICALS - -------------------------------------------------------------------------------- (Exact name of small business issuer as specified in its charter) California 95-2680312 - -------------------------------- ------------------------------------- (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 1444 Santa Anita Avenue, South El Monte, California 91733 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) (626) 442-3141 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) N / A - -------------------------------------------------------------------------------- (Former name, former address and former fiscal year, if changed since last report) As of December 31, 1999, there were outstanding 4,135,162 shares of common stock of the registrant. Transitional Small Business Disclosure Format (check one): Yes No X ---------- ----------- LEE PHARMACEUTICALS BALANCE SHEET DECEMBER 31, 1999 (DOLLARS IN THOUSANDS) (UNAUDITED) ASSETS Cash $ 6 Accounts and notes receivable (net of allowances: $157) 988 Due from related party 204 Inventories: Raw materials $ 1,752 Work in process 197 Finished goods 458 ------------- Total inventories 2,407 Other current assets 409 ------------- Total current assets 4,014 Property, plant and equipment (less accumulated depreciation and amortization: $6,211) 498 Goodwill and other assets, (net of accumulated amortization: $6,892) 3,622 ------------- TOTAL $ 8,134 =============
See notes to financial statements. LEE PHARMACEUTICALS BALANCE SHEET DECEMBER 31, 1999 (DOLLARS IN THOUSANDS) (UNAUDITED) LIABILITIES Bank overdraft $ 127 Note payable to bank 1,647 Current portion - notes payable, other 1,571 Current portion - note payable related party 525 Accounts payable 1,083 Other accrued liabilities 710 Environmental cleanup liability 366 Due to related parties 659 Deferred income 60 --------------- Total current liabilities 6,748 --------------- Long-term notes payable to related parties 2,582 --------------- Long-term notes payable, other 1,053 --------------- Environmental cleanup liability - Casmalia Site 374 --------------- COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' DEFICIENCY Common stock, $.10 par value; authorized, 7,500,00 shares; issued and outstanding, 4,135,162 shares 413 Additional paid-in capital 4,222 Accumulated deficit (7,258) --------------- Total stockholders' deficiency (2,623) --------------- TOTAL $ 8,134 ===============
See notes to financial statements. LEE PHARMACEUTICALS STATEMENTS OF OPERATIONS (DOLLARS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 1999 1998 ------------- ------------- (UNAUDITED) (UNAUDITED) Gross revenues $ 2,537 $ 2,133 Less: Sales returns (193) (127) Cash discounts and others (22) (16) ------------ ------------ Net revenues 2,322 1,990 ------------ ------------ Costs and expenses: Cost of sales 1,068 936 Selling and advertising expense 732 719 General and administrative expense 305 303 Interest expense 216 188 ------------ ------------ Total costs and expenses 2,321 2,146 ------------ ------------ Income (loss) from operations 1 (156) Other income 17 15 ------------ ------------ Net income (loss) before extraordinary item 18 (141) Extraordinary loss related to Casmalia Disposal Site cleanup - (374) ------------ ------------ Net income (loss) $ 18 $ (515) =========== ============ Per share: Basic income (loss) per share before extraordinary loss $ .00 $ (.03) Extraordinary loss - (.09) ------------ ------------ Basic income (loss) $ .00 $ (.12) =========== ============ See notes to financial statements.
LEE PHARMACEUTICALS STATEMENTS OF CASH FLOWS (DOLLARS IN THOUSANDS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 1999 1998 ---------------- --------------- (UNAUDITED) (UNAUDITED) Cash flows from operating activities: Net income (loss).......................................................... $ 18 $ (515) Loss from extraordinary item............................................. - 374 ------------- ------------- Net income (loss) before extraordinary item................................ 18 (141) ------------- ------------- Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation............................................................... 35 33 Amortization of intangibles................................................ 220 209 (Decrease) in deferred income.............................................. (16) (16) (Gain) on disposal of property, plant, and equipment....................... - - Change in operating assets and liabilities: (Increase) decrease in accounts receivable................................. (95) 216 Decrease (increase) in due from related party.............................. 1 (18) (Increase) in inventories ................................................. (76) (181) Decrease (increase) in other current assets................................ 45 (97) (Decrease) increase in accounts payable.................................... (6) 185 Increase in due to related party........................................... 54 58 Increase in notes payable, other........................................... 220 740 Increase (decrease) in other accrued liabilities........................... 54 (34) (Decrease) in accrued royalties............................................ (26) (295) ------------- ------------- Total adjustments.......................................................... 410 800 ------------- ------------- Net cash provided by operating activities................................ 428 659 ------------- ------------- Cash flows from investing activities: Additions to property, plant, and equipment................................ (106) (21) Proceeds from sale of equipment............................................ - - Acquisition of product brands.............................................. (140) (930) ------------- ------------- Net cash (used in) investing activities.................................. (246) (951) ------------- ------------- Cash flows from financing activities: (Payments on) bank loans................................................... (6) (2) (Payments on) proceeds from notes payable, other........................... (209) 326 Increase (decrease) in bank overdraft...................................... 35 (51) ------------- ------------- Net cash (used in) provided by financing activities...................... (180) 273 -------------- ------------- Net increase (decrease) in cash............................................... 2 (19) Cash, beginning of year....................................................... 4 42 ------------- ------------- Cash, end of period........................................................... $ 6 $ 23 ============= ============= SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Cash paid during the year for: Interest................................................................... $ 174 $ 148 ============= ============= Acquisition of product brands: Fair value of assets acquired.............................................. $ 340 $ 1,015 Fair value of liabilities incurred......................................... (200) (85) ------------- ------------- Net cash payments........................................................ $ 140 $ 930 ============= =============
See notes to financial statements. NOTES TO FINANCIAL INFORMATION 1. Basis of presentation: The accompanying balance sheet as of December 31, 1999, and the statements of operations and cash flows for the periods ended December 31, 1999, and 1998, have not been audited by independent accountants but reflect all adjustments, consisting of any normal recurring adjustments, which are, in the opinion of management, necessary to a fair statement of the results for such periods. The results of operations for the three months ended December 31, 1999, are not necessarily indicative of results to be expected for the year ending September 30, 2000. Certain information and footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the requirements of the Securities and Exchange Commission, although the Company believes that the disclosures included in these financial statements are adequate to make the information not misleading. The financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's annual report on Form 10-KSB for the fiscal year ended September 30, 1999. The Company is involved in various matters involving environmental cleanup issues. SEE "Item 2. Management's Discussion and Analysis or Plan of Operations" herein and Note 10 of Notes to Financial Statements included in the Company's Form 10-KSB for the fiscal year ended September 30, 1999. The ultimate outcome of these matters cannot presently be determined. Environmental expenditures that relate to an existing condition caused by past operations, and which do not contribute to current or future revenue generation, are expensed. The Company's proportionate share of the liabilities are recorded when environmental remediation and/or cleanups are probable, and the costs can be reasonably estimated. 2. Basic income (loss) per share: Basic income (loss) per share is based on the weighted average number of shares of common stock outstanding during the periods presented. Common stock equivalents (common stock options) are not included in the calculation for the three months ended December 31, 1999 because the effect was immaterial. Common stock equivalents were not included in the loss for the three months ended December 31, 1998 because their effect on basic loss per share is anti-dilutive. The weighted average number of shares was 4,135,162 for all periods presented. 3. Note payable to bank: Effective April 26, 1996, the Company renewed its real estate loan with the bank. The note payable to the bank, secured by deed on land and building, requires a monthly payment of $4,200, including interest at the bank's reference rate plus 4%, maturing March 2001. At December 31, 1999, the interest rate was 12.5%. The note is guaranteed by the former Chairman of the Company and the Company's President. 4. Line of credit: Effective May 21, 1998, the Company renewed its accounts receivable financing, maturing May 2000, whereby 75% of the eligible domestic accounts receivable, not to exceed the greater of $1,100,000 or $1,100,000 less amounts advanced on inventory, can be advanced. The agreement is renewable for successive one year periods thereafter. Also, the agreement requires minimum monthly interest of $3,000 with an interest rate of 5% above Bank of America's prime rate. The financing agreement includes a $400,000 term loan on inventory which is incorporated in the working capital line of credit above. This term loan requires monthly payments of $11,110 with an interest rate of 6% above Bank of America's prime rate. Additionally, there is a separate $440,000 term loan on the Company's equipment. This financing is secured by a security interest in all of the Company's assets and requires monthly payments of $11,800 including interest at Bank of America's prime rate plus 6%. On October 29, 1999, the Company and it's asset based financing lender mutually agreed to modify the Loan and Security Agreement whereby the maximum revolving advance was increased to $1,400,000 from $1,100,000 based on domestic accounts receivable. All other terms and conditions of the Agreement remain unchanged. 5. Acquisitions: On October 1, 1998, the Company purchased certain assets of the Cheracol-Registered Trademark- cough syrup, Comhist-Registered Trademark- decongestant tablets and Entuss-Registered Trademark- expectorant product lines from Roberts Pharmaceutical Corporation for $684,934. The Company remitted $600,000 at closing and is required to make monthly payments of $3,538, plus interest at prime, commencing January 1, 1999, and ending November 1, 2000. In addition, the Company purchased certain inventory for $150,800 for which the Company is required to make monthly payments of $6,283, plus interest at prime, commencing January 1, 1999, and ending November 1, 2000. On December 1, 1998, the Company purchased certain assets of seven over-the-counter products from Numark Laboratories, Inc. for $430,000. The Company remitted the full $430,000 at closing. On April 23, 1999, the Company purchased certain assets of the Lady Esther-Registered Trademark- facial cream and powder product line from Numark Laboratories, Inc. for $220,000. The Company remitted $220,000 at closing. In addition, the Company purchased certain inventory for $169,000. On June 29, 1999, the Company purchased certain assets of the Take-Off-Registered Trademark-, pre-moistened makeup remover cloths product line from Premier Consumer Products, Inc. and Advanced Polymer Systems, Inc. for $1,000,000. The Company remitted $200,000 at closing and is required to make monthly payments of $32,000 plus interest at prime commencing September 15, 1999 and ending September 15, 2001. In addition, the Company purchased certain inventory for approximately $70,000. On November 15, 1999, the Company purchased certain assets of product lines from U.S. Dermatologics, Inc. which includes Cope-Registered Trademark-, a tension headache relief tablet, and Astring-o-Sol-Registered Trademark-, a concentrated mouthwash, for $400,000. The Company has remitted $200,000 at closing and is required to make twenty-four equal monthly installments of $8,000 plus interest at a rate equal to the highest prime rate (published in the Wall Street Journal) during the preceding month commencing January 25, 2000 and ending on December 25, 2001, and a final payment of all remaining principal due on January 25, 2002. Included in the above purchase price was certain inventories valued at approximately $60,000. ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS MATERIAL CHANGES IN RESULTS OF OPERATIONS THREE MONTHS ENDED DECEMBER 31, 1999, AND DECEMBER 31, 1998 Gross revenues for the three months ended December 31, 1999, were $2,537,000, an increase of approximately $404,000 or 19% from the comparable three months period ended December 31, 1998. The increase in gross revenues was due to the added volume generated from the Lee-Registered Trademark-Lip-Ex-TM- lip balm line plus the recently acquired brands such as: Take-Off-Registered Trademark-, Lady Esther-Registered Trademark-, and seven items purchased from Numark Laboratories, Inc. These newly acquired brand acquisitions accounted for approximately $425,000 or 17% of the Company's total gross revenues. The increase in gross revenues was somewhat offset by the reduced sales of the nail category products, certain over-the-counter items and depilatories. Net revenues increased approximately $332,000 or 17% for the three months ended December 31, 1999, as compared to the three months ended December 31, 1998. The change in net revenues was due to the same explanations discussed above. The Company's sales returns increased approximately $66,000 or 52% when comparing the three months ended December 31, 1999 and 1998. The increase was a result of higher product returns related to prescription drug items. Cost of sales as a percentage of gross revenues was 42% for the three months ended December 31, 1999, compared to 44% for the comparative three months period ended December 31, 1998. The lower cost of sales percentage was due to a favorable product mix along with longer and more efficient production runs. Selling and advertising expenses increased $13,000 or 2% when comparing the three months ended December 31, 1999, with the three months ended December 31, 1998. The increase in expenses was mainly due to the following factors; 1) increased amortization expense ($33,500), the result of recent brand acquisitions, 2) additional cooperative advertising ($48,000), and 3) higher freight costs ($47,000). The above increases were offset by decreases in royalty expense ($82,000) due to the expiration of the write-off period, lower consultant fees ($14,000), and insurance expense ($9,600). General and administrative expenses increased $2,000 when comparing the three months ended December 31, 1999, with the three months ended December 31, 1998. Interest expense increased $28,000 or 15% when comparing the three months ended December 31, 1999, with the three months ended December 31, 1998. The increase was due to increased borrowing from the Company's asset based financing lender and additional liability commitments as a result of recent brand acquisitions. Also, contributing to the increase was a higher prime interest rate, 8.5% versus 7.75%, at December 31, 1999 and December 31, 1998, respectively. LIQUIDITY AND CAPITAL RESOURCES During the three months ended December 31, 1999, working capital was a negative $2,734,000 compared with a negative $2,409,000 as of September 30,1999. The ratio of current assets to current liabilities was .6 to 1 at December 31, 1999, and September 30, 1999. The increase in the Company's negative working capital was due to an increase in borrowing on notes payable, and increases in notes payable to its asset based financing lender. The Company has an accumulated deficit of $7,258,000. The Company's past recurring losses and the nominal profit from operations in fiscal 1997 and the first quarter of fiscal 2000, and inability to generate sufficient cash flow from normal operations to meet its obligations as they come due raise substantial doubt about the Company's ability to continue as a going concern. The Company's ability to continue in existence is dependent upon future developments, including retaining current financing and achieving a level of profitable operations sufficient to enable it to meet its obligations as they become due. YEAR 2000 READINESS Most companies have computer systems that use two digits to identify a year in the date field (e.g. "99" for 1999). These systems must be modified to handle turn-of-the century calculations. If not corrected, systems failures or miscalculations could occur, potentially causing disruptions of operations, including, among other things, the inability to process transactions, send invoices, or engage in other normal business activities. This creates potential risk for all companies, even if their own computer systems are Year 2000 compliant. In 1998, the Company initiated a comprehensive review of its computer systems to identify processes that could be adversely affected by Year 2000 issues. In addition, the Company identified computer application systems that required modification or replacement. The Company communicated with suppliers, vendors, and lenders to determine the extent to which those companies are addressing Year 2000 compliance issues. The Company currently estimates that the total cost for the Year 2000 project will be approximately $100,000. During fiscal year 1999, the Company incurred approximately $73,000 for charges related to its Year 2000 remediation effort. The remediation costs include internal labor costs, as well as fees and expenses paid to outside contractors specifically associated with programming and purchased hardware and upgraded software. The Company incurred approximately $13,000 in Year 2000 modication expenses during the quarter ended December 31, 1999. As of the date of this report, the Company has not experienced any material Year 2000 related problems. Based on currently available information, management does not believe that the Year 2000 matters discussed above will have a material adverse impact on the Company's financial condition or results of operations; however, because of the uncertainties in this area, no assurances can be given in this regard. ENVIRONMENTAL MATTERS The Company owns a manufacturing facility located in South El Monte, California. The California Regional Water Quality Control Board (The "RWQCB") ordered the Company in 1988 and 1989 to investigate the contamination on its property (relating to soil and groundwater contamination). The Company engaged a consultant who performed tests and reported to the then Chairman of the Company. The Company resisted further work on its property until the property upgradient was tested in greater detail since two "apparent source" lots had not been tested. On August 12, 1991, the RWQCB issued a "Cleanup and Abatement Order" directing the Company to conduct further testing and cleanup the site. In October 1991, the Company received from an environmental consulting firm an estimate of $465,200 for investigation and cleanup costs. The Company believed that this estimate was inconclusive and overstated the contamination levels. The Company believes that subsequent investigations will support the Company's conclusions about that estimate. The Company did not complete the testing for the reasons listed above as well as "financial constraints". In June 1992 the RWQCB requested that the EPA evaluate the contamination and take appropriate action. At the EPA's request, Ecology & Environment, Inc. conducted an investigation of soil and groundwater on the Company's property. Ecology & Environment Inc.'s Final Site Assessment Report, which was submitted to the EPA in June 1994, did not rule out the possibility that some of the contamination originated on-site, and resulted from either past or current operations on the property. The Company may be liable for all or part of the costs of remediating the contamination on its property. The EPA has not taken any further action in this matter, but may do so in the future. The Company and nearby property owners, in consort with their comprehensive general liability (CGL) carriers, have engaged a consultant to perform a site investigation with respect to soil and shallow groundwater contamination over the entire city block. The CGL carriers provided $290,000 in funding which paid for the $220,000 study, $20,000 in legal fees for project oversight, and a $50,000 balance in the operating fund. Earlier the Company had accrued $87,500 as its proportionate share of the earlier quote of $175,000. Since that time, the overall scope of the project was increased to $205,000 plus $15,000 for waste water disposal, bringing the total to the above listed $220,000. The $87,500 accrual was not spent on this project (as the entire cost was borne by the CGL carriers), but remains on the books as an accrual against the cost of remediation of the same site that was included in the study. The tenants of nearby properties upgradient have sued the Company alleging that hazardous materials from the Company's property caused contamination on the properties leased by the tenants. The case name is DEL RAY INDUSTRIAL ENTERPRISES, INC. v. ROBERT MALONE, ET AL., Los Angeles County Superior Court, Northwest District, commenced August 21, 1991. In this action, the plaintiff alleges environmental contamination by defendants of its property, and seeks a court order preventing further contamination and monetary damages. The Company does not believe there is any basis for the allegations and is vigorously defending the lawsuit. The Company's South El Monte manufacturing facility is also located over a large area of possibly contaminated regional groundwater which is part of the San Gabriel Valley Superfund site. The Company has been notified that it is a potentially responsible party ("PRP") for the contamination. In 1995, the Company was informed that the EPA estimated the cleanup costs for the South El Monte's portion of the San Gabriel Valley Superfund site to be $30 million. The Company's potential share of such amount has not been determined. Superfund PRPs are jointly and severally liable for superfund site costs, and are responsible for negotiating among themselves the allocation of the costs based on, among other things, the outcome of environmental investigation. In August 1995 the Company was informed that the EPA entered into an Administrative Order of Consent with Cardinal Industrial Finishes ("Cardinal") for a PRP lead remedial investigation and feasibility study (the "Study") which, the EPA states, will both characterize the extent of groundwater contamination in South El Monte and analyze alternatives to control the spread of contamination. The Company and others have entered into the South El Monte Operable Unit Site Participation Agreement with Cardinal pursuant to which, among other things, Cardinal will contract with an environmental firm to conduct the Study. The Study has been completed. The Company's share of the cost of the Study is currently $15,000 and was accrued for in the financial statements as of September 30, 1995. The South El Monte Operable Unit (SEMOU) participants developed four remedial alternatives. The capital cost of the four alternatives range from $0 (no action) up to $3.49 million. The estimated annual operating cost of the four alternatives range from $0 (no action) to $770,300. Over a 30-year period, the total cost of the four alternatives range from $0 (no action) up to $13.05 million. The EPA prefers an alternative which estimates the capital cost up to $3.08 million, the annual operating cost at $.48 million, and the 30-year period total cost up to approximately $9.09 million. The selection of the actual alternative implemented is subject to public comment. At the present time, the Company does not know what its share of the cost may be, if any. Therefore, no additional accrual has been recognized as a liability on the Company's books. The City of South El Monte, the city in which the Company has its manufacturing facility, is located in the San Gabriel Valley. The San Gabriel Valley has been declared a Superfund site. The 1995 Water Quality Control Plan issued by the California Regional Water Quality Control Board states that the primary groundwater basin pollutants in the San Gabriel Valley are volatile organic compounds from industry, nitrates from subsurface sewage disposal and past agricultural activities. In addition, the Plan noted that hundreds of underground storage tanks leaking gasoline and other toxic chemicals have existed in the San Gabriel Valley. The California Department of Toxic Substance Control have declared large areas of the San Gabriel Valley to be environmentally hazardous and subject to cleanup work. The Company believes the City of South El Monte does not appear to be located over any of the major plumes. However, the EPA recently announced it is studying the possibility that, although the vadose soil and groundwater, while presenting cleanup problems, there may be a contamination by DNAPs (dense non-aqueous phase liquids), i.e., "sinkers", usually chlorinated organic cleaning solvents. The EPA has proposed to drill six "deep wells" throughout the City of South El Monte at an estimated cost of $1,400,000. The EPA is conferring with SEMPOA (South El Monte Property Owners Association) as to cost sharing on this project. SEMPOA has obtained much lower preliminary cost estimates. The outcome cost and exact scope of this are unclear at this time. The Company and other property owners engaged Geomatrix Consultants, Inc., to do a survey of vadose soil and shallow groundwater in the "hot spots" detected in the previous studies. Geomatrix issued a report dated December 1, 1997 (the "Report"), on the impact of volatile organic compounds on the soil and groundwater at the Lidcombe and Santa Anita Avenue site located in South El Monte, California (which includes the Company's facilities). The Report indicated generally low concentrations of tetrachloroethene, trichloaethene and trichloroethane in the groundwater of the upgradient neighbor. The Report was submitted to the RWQCB for its comments and response. A meeting with the parties and RWQCB was held on February 10, 1998. The RWQCB had advised companies that vadose soil contamination is minimal and requires no further action. However, there is an area of shallow groundwater which has a higher than desired level of chlorinated solvents, and the RWQCB requested a proposed work plan be submitted by Geomatrix. Geomatrix has submitted a "Focused Feasibility Study" which concludes that there are five possible methods for cleanup. The most expensive are for a pump and sewer remediation which would cost between $1,406,000 and $1,687,000. The Company is actively exploring the less expensive alternative remediation methods, of which the two proposed alternatives range in cost between $985,000 and $1,284,000. Accordingly, the Company has taken the average of the two amounts ($985,000 and $1,284,000) as the total amount of estimated cost. Since there are four economic entities involved, the Company's best estimate at this time, in their judgment, would be that their forecasted share would be 25% or $284,000 less the liability already recognized on the books of $162,000 thereby requiring an additional $122,000 liability. Accordingly, the Company recorded an additional accrual of $122,000 in the third quarter of fiscal 1998. The $122,000 accrual is in addition to the $79,000 accrual for the Monterey Site as will be explained in the following paragraph. The $79,000 accrual, in the third quarter of fiscal 1998, related to the Monterey Site is not included in the $284,000 figure above. No assurances can be given that any of the alternative remediation methods will be feasible or that the actual cost to the Company of the remediation will not exceed the amount of the Company's current accruals of $284,000 (which includes the $122,000 charge to income in the third quarter of fiscal 1998). Without any prior correspondence or inkling of the Company's potential liability, the EPA has recently informed the Company that the Company may have potential liability for the ongoing remediation of Operating Industries, Inc. (as they have gone out of business) Landfill Superfund Site in Monterey Park, California (the "Monterey Site"). The Monterey Site is a 190 acre landfill that operated from 1948 to 1984, in which the Company disposed of non toxic pH balanced waste water on six occasions between 1974 and 1978. Over 4,000 companies have been identified as having contributed waste to the Monterey Site. The EPA has offered to settle the Company's potential liability with respect to the Monterey Site for a cost to the Company of $79,233. The Company accrued a $79,000 charge in the third quarter of fiscal 1998 with respect to this possible liability. The Company has elected to file for relief from these obligations under the financial hardship option in the EPA's response form. The Company has been notified by the EPA that the Company may have potential liability for waste material it disposed of at the Casmalia Disposal Site ("Site") located on a 252-acre parcel in Santa Barbara County, California. The Site was operational from 1973 to 1989 and over 10,000 separate parties disposed of waste there. The EPA stated that federal, state and local governmental agencies along with the numerous private entities that used the Site for waste disposal will be expected to pay their share as part of this settlement. The U.S. EPA is also pursuing the owner(s)/operator(s) of the Site to pay for Site remediation. The EPA has a settlement offer to the Company with respect to the Site for a cost of $373,950. The Company accrued a $374,000 charge in the first quarter of fiscal 1999 with respect to this possible liability. The Company has elected to file for relief from these obligations under the financial hardships option in the EPA's response form. The total amount of environmental investigation and cleanup costs that the Company may incur with respect to the foregoing is not known at this time. However, based upon information available to the Company at this time, the Company has expensed since 1988 a total of $860,000, of which $89,000 were legal fees, exclusive of legal fees expended in connection with the SEC environmental investigation. The actual costs could differ materially from the amounts expensed for environmental investigation and cleanup costs to date. PART II - OTHER INFORMATION Item 1. Legal Proceedings The information set forth under Part I, Item 2, "Management's Discussion and Analysis or Plan of Operations - Environmental Matters" is incorporated herein by reference. SEE ALSO "Legal Proceedings" in the Company's Form 10-KSB for the fiscal year ended September 30, 1999. Item 6. The following exhibits are filed herewith: 10.1 Promissory note evidencing advance made to the Registrant 10.2 Modification of loan and security agreement dated October 29, 1999, between Lee Pharmaceuticals and Finova Capital Corporation (formerly Preferred Business Credit, Inc.) regarding a revolving credit facility financing 10.3 Modification of secured (by inventory) promissory note dated October 29, 1999, between Lee Pharmaceuticals and Finova Capital Corporation (formerly Preferred Business Credit, Inc.) 10.4 Modification of secured (by equipment) promissory note dated October 29, 1999, between Lee Pharmaceuticals and Finova Capital Corporation (formerly Preferred Business Credit, Inc.) 27 - Financial Data Schedule The following exhibits have previously been filed by the Company: 3.1 - Articles of Incorporation, as amended (1) 3.4 - By-laws, as amended December 20, 1977 (2) 3.5 - Amendment of By-laws effective March 14, 1978 (2) 3.6 - Amendment to By-laws effective November 1, 1980 (3) (1) Filed as an Exhibit of the same number with the Company's Form S-1 Registration Statement filed with the Securities and Exchange Commission on February 5, 1973, (Registrant No. 2-47005), and incorporated herein by reference. (2) Filed as Exhibits 3.4 and 3.5 with the Company's Form 10-K Annual Report for the fiscal year ended September 30, 1978, filed with the Securities and Exchange Commission and incorporated herein by reference. (3) Filed as an Exhibit of the same number with the Company's Form 10-K Annual Report for the fiscal year ended September 30, 1979, filed with the Securities and Exchange Commission and incorporated herein by reference. SIGNATURES In accordance with the requirements of the Securities Exchange Acts of 1934, the registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized. LEE PHARMACEUTICALS ------------------- (Registrant) Date: February 9, 2000 /s/ RONALD G. LEE ---------------------- -------------------------------------- Ronald G. Lee Chairman of the Board, President and Chief Financial and Accounting Officer EX-10.1 2 EXHIBIT 10.1 EXHIBIT 10.1 Page 1 of 1 - ------------------------------------------------------------------------------- STRAIGHT NOTE $200,000 South El Monte, California November 11, 1999 - ----------------- For value received, Lee Pharmaceuticals promises to pay Mark DiSalvo or order, at South El Monte, California the sum of TWO HUNDRED THOUSAND DOLLARS, with interest from November 11, 1999, on unpaid principal at the rate of twenty (20) per cent per annum; principal is payable monthly, commencing on December 25, 1999, with monthly principal payments of $10,000. Interest shall be calculated on the basis of the unpaid principal balance daily, based on a 365-day year, actual day month and payable monthly. Principal and interest shall be payable in lawful money of the United States. If action were instituted on this note, I promise to pay such sum as the Court may fix as attorney's fees. This note is secured by the following trademarks; Cope and Astring-o-Sol. 11/29/99 /s/ Ronald G. Lee - -------------------- -------------------------------------- Date Lee Pharmaceuticals - Ronald G. Lee 11/24/99 /s/ Michael L. Agresti - -------------------- ------------------------------------------------ Date Lee Pharmaceuticals - Michael L. Agresti - ------------------------------------------------------------------------------- EX-10.2 3 EXHIBIT 10.2 EXHIBIT 10.2 [LOGO] LOAN AND SECURITY AGREEMENT LEE PHARMACEUTICALS Borrower 1444 Santa Anita Avenue, South El Monte, CA 91733 Address 95-2680312 Borrower Fed ID Tax No. $1,400,000.00 Credit Limit October 29, 1999 Date ---------------------------------------------------------------------- FINOVA GROWTH FINANCE ---------------------------------------------------------------------- April 1999
TABLE OF CONTENTS 1. DEFINITIONS AND CONSTRUCTION........................................... 1 1.1 Definitions .................................................... 1 1.2 Accounting Terms ............................................... 4 1.3 Code .......................................................... 5 1.4 Construction ................................................... 5 1.5 Exhibits ...................................................... 5 2. LOANS; INTEREST RATE AND OTHER CHARGES................................. 5 2.1 Revolving Advances ............................................ 5 2.2 Term Loan ..................................................... 5 2.3 Overadvance ................................................... 5 2.4 Interest: Rate; Payments; and Calculation ..................... 5 2.5 Crediting Payments ............................................ 6 2.6 Statements of Obligations ...................................... 6 2.7 Fees .......................................................... 6 2.8 Term; Automatic Renewal ....................................... 7 2.9 Effect of Termination ......................................... 7 2.10 Early Termination by Borrower ................................. 7 2.11 Termination Upon Event of Default ............................. 7 3. SECURITY............................................................... 7 3.1 Grant of Security Interest ..................................... 8 3.2 Negotiable Collateral .......................................... 8 3.3 Collection of Accounts, Negotiable Collateral .................. 8 3.4 Delivery of Additional Documentation Required .................. 8 3.5 Power of Attorney .............................................. 8 3.6 Right To Inspect ............................................... 8 4. CONDITIONS OF CLOSING.................................................. 8 4.1 Initial Advance.................................................. 8 4.2 Subsequent Advances.............................................. 9 5. REPRESENTATIONS AND WARRANTIES......................................... 9 5.1 No Prior Encumbrances............................................ 9 5.2 Bona Fide Accounts............................................... 9 5.3 Merchantable Inventory and Inventory Records..................... 9 5.4 Location of Inventory and Equipment.............................. 9 5.5 Location of Principal Place of Business/Chief Executive Office/Residence................................................. 9 5.6 Due Organization and Qualification............................... 9 5.7 Due Authorization; No Conflict ................................ 10 5.8 Litigation .................................................... 10 5.9 No Material Adverse Change in Financial Statements ............. 10 5.10 Solvency ...................................................... 10 5.11 ERISA ......................................................... 10 5.12 Environmental Condition ........................................ 10 5.13 Reliance by FINOVA; Cumulative.................................. 11 5.14 Year 2000 Representations & Warranties.......................... 11 Page I 6. COVENANTS............................................................. 11 6.1 Affirmative Covenants 6.1.1 Accounting System........................................ 11 6.1.2 Collateral Reports....................................... 11 6.1.3 Assignments of Accounts.................................. 11 6.1.4 Financial Statements, Reports, Certificates.............. 11 6.1.5 Tax Returns, Receipts.................................... 12 6.1.6 Guarantor Reports........................................ 12 6.1.7 Designation of Inventory and Returns..................... 12 6.1.8 Title to Equipment....................................... 12 6.1.9 Maintenance of equipment................................. 12 6.1.10 Taxes.................................................... 13 6.1.11 Insurance................................................ 13 6.1.12 FINOVA Expenses.......................................... 13 6.1.13 Year 2000 Covenants...................................... 13 6.2 Negative Covenants ............................................ 13 6.2.1 Extraordinary Transactions and Disposal of Assets........ 13 6.2.2 Change Name.............................................. 14 6.2.3 Merge, Acquire........................................... 14 6.2.4 Guarantee................................................ 14 6.2.5 Restructure.............................................. 14 6.2.6 Prepayment............................................... 14 6.2.7 Change of Ownership...................................... 14 6.2.8 Capital Expenditures..................................... 14 6.2.9 Consignments ............................................ 14 6.2.10 Distributions............................................ 14 6.2.11 Accounting Methods....................................... 14 6.2.12 Investments ............................................. 14 6.2.13 Transactions with Affiliates ............................ 14 7. DEFAULTS AND REMEDIES................................................. 15 7.1 Defaults......................................................... 15 7.2 Remedies ................................................ 16 7.3 Remedies Cumulative ............................................ 17 8. EXPENSES AND INDEMNITIES.............................................. 17 9. MISCELLANEOUS......................................................... 18 9.1 Demand; Protest; etc. ........................................ 18 9.2 FINOVA's Liability for Inventory or Equipment................... 18 9.3 NOTICES......................................................... 18 9.4 CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER...................... 19 9.5 DESTRUCTION OF BORROWER'S DOCUMENTS............................. 19 9.6 Effectiveness ................................................. 19 9.7 Successors and Assigns ........................................ 19 9.8 Section Headings .............................................. 19 9.9 Interpretation ................................................ 19 9.10 Publicity .............................................. 20 9.11 Severability of Provisions .................................... 20 9.12 Amendments in Writing ......................................... 20 9.13 Counterparts ................................................. 20
Page II This LOAN AND SECURITY AGREEMENT, is entered into as of October 29, 1999, between FINOVA CAPITAL CORPORATION, a Delaware corporation ("FINOVA"), located at 355 South Grand Avenue, Suite 2400, Los Angeles, California 90071, and LEE PHARMACEUTICALS ("Borrower") located at 1444 Santa Anita Avenue, South El Monte, CA 91733. The parties agree as follows: 1. DEFINITIONS AND CONSTRUCTION 1.1 DEFINITIONS. As used this Agreement, the following terms shall have the following definitions: "Accounts" means all presently existing and hereafter arising accounts, contract rights, and all other forms of obligations owing to Borrower arising out of the sale or lease of goods or the rendition of services by borrower, whether or not earned by performance, and any and all credit insurance, guaranties, and other security therefor, as well as all merchandise returned to or reclaimed by borrower and borrower's books relating to any of the foregoing. "Agreement" means this Loan And Security Agreement and any extensions, riders, supplements, notes, amendments, or modifications to or in connection with this Loan And Security Agreement. This Loan and Security Agreement amends and supercedes that Loan and Security Agreement dated May 21, 1996. "Authorized Officer" means any officer of Borrower authorized in writing to transact business with FINOVA. "Base Rate" means the variable rate of interest, per annum, most recently announced by CITIBANK N.A., (or any successor thereto), from time to time as its "base rate", which may not be such institution's lowest rate (the "Base Rate"), with the understanding that the "Base rate" merely serves as a basis upon which effective rates of interest are calculated for loans making reference thereto and may not be the lowest or best rate available from such financial institution. "Borrower's Books" means all of the Borrower's books and records including: ledgers; records indicating, summarizing, or evidencing Borrower's assets or liabilities, or the Collateral; all information relating to Borrower's business operations or financial condition; and all computer programs, disk or tape files, printouts, runs, or other computer prepared information, and the equipment containing such information. "Borrowing Base" has the meaning set forth in Section 2.1. "Business Day" means any day, which is not a Saturday, Sunday, or other day on which banks in the state of California are authorized or required to close. "Code" means the California Uniform Commercial Code. "Collateral" means each of the following: the Accounts; the Equipment; the General Intangibles; the Inventory; the Negotiable Collateral; the Investment Property; any money, or other assets of Borrower which hereafter come into the possession, custody, or control of FINOVA and the proceeds and products, whether tangible or intangible, of any of the foregoing, including proceeds of insurance covering any or all of the Collateral, and any and all Accounts, Equipment, General Intangibles, Investment Property, Negotiable Collateral, money, deposit accounts, or other tangible or intangible property resulting from the sale or other disposition of the Collateral, or any portion thereof or interest therein, and the proceeds thereof. 1 "Daily Balance" means the amount of the Obligations owed by Borrower at the end of a given day. "Eligible Accounts" means those Accounts created by Borrower in the ordinary course of business arising out of Borrower's sale of goods or rendition of services, which have been validly assigned and strictly comply with all of Borrower's representations and warranties to FINOVA, and which are and at all times shall continue to be acceptable to FINOVA in all respects; PROVIDED, HOWEVER, that standards of eligibility may be fixed and revised from time to time by FINOVA in FINOVA's exclusive judgment. Eligible Accounts shall not include the following: (a) Accounts which the account debtor has failed to pay within NINETY (90) days of invoice date; (b) Accounts with selling terms of more than thirty (30) days; (c) Accounts with respect to which the account debtor is an officer, employee, or agent of Borrower; (d) Accounts with respect to which goods are placed on consignment, guaranteed sale, sale or return, sale on approval, bill and hold, or other terms by reason of which the payment by the account debtor may be conditional; (e) Accounts with respect to which the account debtor is not a resident of the United States, and which are not either (1) covered by credit insurance in form and amount, and by an insurer, satisfactory to FINOVA, or (2) supported by one or more letters of credit in favor of FINOVA as co-beneficiary, in an amount and of a tenor, and issued by a financial institution, acceptable to FINOVA; (f) Accounts with respect to which the account debtor is the United States or any department, agency, or instrumentality of the United States, any State of the United States, or any city, town, municipality, or division thereof; (g) Accounts with respect to which the account debtor is a subsidiary of, related to, affiliated with or has common shareholders, officers or directors with Borrower; (h) Accounts with respect to which Borrower is or may become liable to the account debtor for goods sold or services rendered by the account debtor to Borrower; (i) Accounts with respect to an account debtor whose total obligations to Borrower exceed ten percent (10%) of all Eligible Accounts to the extent such obligations exceed the aforementioned percentage; (j) Accounts with respect to which the account debtor disputes liability or makes any claim with respect thereto, or is subject to any insolvency proceeding, or becomes insolvent, fails, or goes out of business; and (k) Accounts the collection of which FINOVA believes to be doubtful by reason of the account debtor's financial condition. "Eligible Inventory" means Inventory consisting of first quality finished goods held for resale in the ordinary course of Borrower's business and raw materials for such finished goods, which are located at Borrower's premises and acceptable to FINOVA in all respects. Eligible Inventory shall not include work in process, components which are not part of finished goods, spare parts, packaging and Shipping materials, supplies used or consumed in Borrower's business, Inventory at the premises of third parties or subject to a security interest or lien in favor of any third party, bill and hold goods, inventory 2 which is not subject to FINOVA's perfected security interest, returned and/or defective goods, "seconds" and Inventory purchased on consignment. Eligible Inventory shall be valued at the lower of Borrower's cost or market. "Equipment" means all of Borrower's present and hereafter acquired machinery, machine tools, motors, equipment, furniture, furnishings, fixtures, motor vehicles, tools, parts, dies, jigs, goods (other than consumer goods or farm products), and any interest in any of the forgoing, and all attachments, accessories, accessions, replacements, substitutions, additions, and improvements to any of the forgoing, wherever located. "ERISA" means the Employee Retirement Income Security Act of 1974, as amended, and the regulations thereunder. "ERISA" Affiliate" means each trade or business (whether or not incorporated and whether or not foreign) which is or may hereafter become a member of a group of which Borrower is a member and which is treated as a single employer under ERISA Section 4001(b)(1), or IRC Section 414. "FINOVA Expenses" means all: costs or expenses (including taxes and insurance premiums) required to be paid by Borrower under any of the Loan Documents which are paid or advanced by FINOVA: filing, recording, publication, appraisal, and search fees paid or incurred by FINOVA in connection with FINOVA's transactions with Borrower; costs and expenses incurred by FINOVA in the disbursement of funds to Borrower (by wire transfer or otherwise); charges resulting from the dishonor of checks; costs and expenses incurred by FINOVA to correct any default or enforce any provision of the Loan Documents, or in gaining possession of, maintaining, handling, preserving, storing, shipping, selling, preparing for sale, or advertising to sell the Collateral, or any portion thereof, whether or not a sale is consummated; costs and expenses of auditing Borrower; costs and expenses of third party claims or any suit incurred by FINOVA in enforcing or defending the Loan Documents; and FINOVA's reasonable attorney's fees and expenses incurred in advising, structuring, drafting, reviewing, administering, amending, terminating, enforcing, defending, or concerning the Loan Documents, whether or not suit is brought. "GAAP" means generally accepted accounting principles as in effect from time to time. "General Intangibles" means all of Borrower's present and future general intangibles and other personal property (including choses or things in action, goodwill, patents, trade names, trademarks, servicemarks, copyrights, blue prints, drawings, purchase orders, customer lists, monies due or recoverable from pension funds, route lists, monies due under any royalty or licensing agreements, infringement claims, computer programs, computer discs, computer tapes, literature, reports, catalogs, deposit accounts, insurance premium rebates, tax refunds, and tax refund claims) other than goods and Accounts, and Borrower's Books relating to any of the foregoing. "Insolvency Proceeding" means any proceeding commenced by or against any person or entity under any provision of the United States Bankruptcy Code, as amended, or under any other bankruptcy or insolvency law, including assignments for the benefit of creditors, formal or informal moratoria, compositions, or extensions generally with its creditors. "Inventory" means all present and future inventory in which borrower has any interest, including goods held for sale or lease or to be furnished under a contract of service and all of Borrower's present and future raw materials, work in process, finished goods, and packaging and shipping materials, wherever located, and any documents of title representing any of the above, and Borrower's books relating to any of the foregoing. 3 "Investment Property" means all of Borrower's presently existing and hereafter acquired or arising investment property (as that term is defined in Section 9115 of the Code). "IRC" means the Internal Revenue Code of 1986, as amended, and regulations thereunder. "Judicial Officer or Assignee" means any trustee, receiver, controller, custodian, assignee for the benefit of creditors, or any other person or entity having powers or duties like or similar to the powers and duties of a trustee, receiver, controller, custodian, or assignee for the benefit of creditors. "Loan Documents" means, collectively, this Agreement, any note or notes (including the term note) executed by Borrower to the order of FINOVA, and any other agreement entered into between Borrower and FINOVA in connection with this Agreement. "Multiemployer plan" means a "multiemployer plan" as defined in ERISA Section 3(37) or 4001(a)(3) or IRC Section 414(f), which covers employees of the Borrower of any ERISA Affiliate. "Negotiable Collateral" means all of Borrower's present and future letters of credit, notes, drafts, instruments, documents, leases, and chattel paper, and Borrower's books relating to any of the foregoing. "Obligations" means all loans, advances, debts, principal, interest (including any interest which, but for the provisions of the United States Bankruptcy Code, would have accrued), premiums, liabilities (including all amounts charged to Borrower's loan account pursuant to any agreement authorizing FINOVA to charge Borrower's loan account), obligations, fees (including early termination fees), lease payments, guaranties, covenants, and duties owing by Borrower to FINOVA of any kind and description (whether pursuant to or evidenced by the Loan Documents, by any note or other instrument, or by any other agreement between FINOVA and Borrower, and whether or not for the payment of money), whether direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, and including any debt, liability, or obligation owing from Borrower to others which FINOVA may have obtained by assignment or otherwise, and further including all interest not paid when due and all FINOVA Expenses which Borrower is required to pay or reimburse by the Loan Documents, by law, or otherwise. "Overadvance" has the meaning set forth in SECTION 2.3. "PBGC" means the Pension Benefit Guarantee Corporation. "Plan" means any plan described in ERISA Section 3(2) maintained for employees of Borrower or any ERISA Affiliate, other than a Multiemployer plan. "Prohibited Transaction" means any transaction described in Section 406 of ERISA, which is not exempt by reason of Section 408 of ERISA, and any transaction, described in Section 4975(c) of the IRC, which is not exempt by reason of Section 4975(c)(2) of the IRC. "Reportable Event" means a reportable event described in Section 4043 of ERISA or the regulations thereunder, a withdrawal from a plan described in Section 4063 of ERISA, or a cessation of operations described in Section 4068(f) of ERISA. "Term Note" has the meaning set forth in SECTION 2.2. 1.2 ACCOUNTING TERMS. All accounting terms not specifically defined herein shall be construed in accordance with GAAP. When used herein, the term "financial statements" shall include the notes and schedules thereto. 4 1.3 CODE. Any terms used in this Agreement, which are defined in the Code, shall be construed and defined as set forth in the Code unless otherwise defined herein. 1.4 CONSTRUCTION. Unless the context of this Agreement clearly requires otherwise, references to the plural include the singular, to the singular include the plural. The words "hereof," "herein," "hereby," "hereunder," and similar terms in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement. Section, sub-section, clause, and exhibit references are to this Agreement unless otherwise specified. 1.5 EXHIBITS. All of the exhibits attached to this Agreement shall be deemed incorporated herein by reference. 2. LOANS; INTEREST RATE AND OTHER CHARGES 2.1 REVOLVING ADVANCES. Subject to the terms and conditions of this Agreement, FINOVA agrees to make revolving advances to Borrower in an amount not to exceed the Borrowing Base. For purposes of this Agreement "Borrowing Base" shall mean the sum of: (a) An amount equal to the lesser of: (I) SEVENTY FIVE PERCENT (75%) of the amount of Eligible Accounts; and (II) an amount equal to Borrower's cash collections for the immediately preceding forty-five (45) day period; plus (b) An amount equal to the least of: (I) TWENTY FIVE PERCENT (25%) of the amount of Eligible Inventory, (II) the outstanding balance of advances against Eligible Accounts and (III) FOUR HUNDRED THOUSAND AND 00/100 DOLLARS ($400,000.00) evidenced by a Secured Promissory Note dated May 15, 1998. FINOVA shall have no obligation to make advances hereunder to the extent they would cause the outstanding balance of revolving advances under this SECTION 2.1 to exceed a maximum amount of ONE MILLION FOUR HUNDRED THOUSAND AND 00/100 DOLLARS ($1,400,000.00). FINOVA is authorized to make advances under this Agreement based upon telephonic or other instructions received from anyone purporting to be an officer, employee or representative of Borrower, or without instructions if in FINOVA's discretion such advances are necessary to meet Obligations. FINOVA will charge the amount of advances made under this SECTION 2.1 to Borrower's loan account. Amounts borrowed pursuant to this SECTION 2.1 may be repaid and reborrowed at any time during the term of this Agreement so long as no Event of default has occurred and is continuing. 2.2 TERM LOAN. FINOVA has agreed to make a term loan to Borrower evidenced by, and repayable in accordance with, that certain Secured Promissory Note, of even date herewith, by Borrower to the order of FINOVA, in the original principal amount of N/A (the "Term Note"). Obligations owing under the Term Note shall constitute Obligations, and the Term Note, together with each amendment, extension, supplement, or replacement thereto, shall be deemed to be a Loan Document. 2.3 OVERADVANCES. If, at any time or for any reason, the amount of Obligations owed by Borrower to FINOVA, pursuant to SECTION 2.1 is greater than the dollar or percentage limitation set forth in SECTION 2.1 (an "overadvance"), Borrower shall immediately pay to FINOVA, in cash, the amount of such excess, plus any fees owing pursuant to SECTION 2.7(b). 2.4 INTEREST: RATE; PAYMENTS; AND CALCULATIONS. (a) INTEREST RATE. Except as specified to the contrary in any Loan Document, the obligations shall bear interest, on the average Daily Balance, at a rate of FIVE PERCENTAGE POINTS (5%) above the Base Rate. 5 (b) DEFAULT RATE. All obligations shall bear interest, from and after the occurrence of an Event of Default, at a rate of TEN PERCENTAGE POINTS (10%) above the Base Rate. (c) MINIMUM INTEREST. In no event shall interest chargeable hereunder be less than ONE percent (1.0%) per month, nor less than THREE THOUSAND AND 00/100 DOLLARS ($3,000.00) per month. (d) PAYMENTS. Interest hereunder shall be due and payable on the first Business Day of each calendar month during the term hereof. FINOVA shall, at its option, charge such interest and all FINOVA Expenses to Borrower's loan account, which amounts shall thereafter accrue interest at the rate then applicable hereunder. (e) COMPUTATION. The Base Rate as of this date is EIGHT AND ONE QUARTER PERCENT (8.25%) per annum. In the event the Base Rate is changed from time to time hereafter, the applicable rate of interest hereunder shall be increased or decreased by an amount equal to the Base Rate change on the effective date of such change. All interest chargeable under the Loan Documents shall be computed on the basis of a three hundred sixty (360) day year for the actual number of days elapsed. 2.5 CREDITING PAYMENTS. The receipt of any wire transfer of funds, check, or other item of payment by FINOVA shall be immediately applied to conditionally reduce Obligations, but shall not be considered a payment on account unless such wire transfer is of immediately available federal funds and is made to the appropriate deposit account of FINOVA or unless and until such check or other item of payment is honored when presented for payment. For interest calculation purposes, the receipt of any check, wire transfer, or other item of payment by FINOVA shall be deemed to have been paid to FINOVA FIVE (5) calendar days after the date FINOVA actually receives such wire transfer or possession of such check or other item of payment. Notwithstanding anything anything to the contrary contained herein, any wire transfer or payment received by FINOVA after 10:00 a.m. Los Angeles time shall be deemed to have been received by FINOVA as of the opening of business on the immediately following business day. 2.6 STATEMENT OF OBLIGATIONS. FINOVA shall render statements to Borrower of the Obligations, including all statements of principal, interest, fees, and FINOVA Expenses owing, and such statements shall be conclusively presumed to be correct and accurate and constitute an account stated between Borrower and FINOVA unless, within thirty (30) days after receipt thereof by Borrower, Borrower shall deliver to FINOVA by registered or certified mail at its address specified herein above, written objection thereto describing the error or errors, if any, contained in any such statements. 2.7 FEES. Borrower shall pay to FINOVA the following fees: (a) INITIAL FACILITY FEE. Concurrently with the execution and delivery of this Agreement, a fee (the "Initial Facility Fee") in the amount of THREE THOUSAND AND 00/100 Dollars ($3,000.00). The Initial Facility Fee shall be fully earned at the time of payment and non-refundable; (b) OVERADVANCE FEE. Upon the occurrence of any Overadvance, a fee in an amount equal to one percent (1%) of the dollar amount of such Overadvance, and every thirty (30) days thereafter that an Overadvance, or any portion thereof, remains outstanding, a fee in an amount equal to one percent (1%) of the highest dollar amount of Overadvance existing on any day during the previous thirty (30) day period. (c) ANNUAL FACILITY FEE. On each anniversary date of the effective date of this Agreement while any Obligations are outstanding, a fee (the "Annual Facility Fee") in the amount equal to one percent (1%) of the maximum amount of revolving advances allowable under SECTION 2.1. The Annual Facility Fee shall be fully earned at the time of payment and non-refundable. 6 (d) FINANCIAL EXAMINATION AND APPRAISAL. FINOVA's customary fee of Five Hundred Dollars ($500) per day per examiner, plus out-of pocket expenses for each financial analysis and examination of Borrower performed by FINOVA or its agents. (e) COLLATERAL MANAGEMENT FEE. On the first day of each month while this Agreement remains in effect, a fee (the "Collateral Management Fee") in an amount equal to N/A% of Borrower's net sales for the preceding month. The Collateral Management fee shall be based upon Borrower's sales as assigned/or reported to FINOVA each month. 2.8 TERM; AUTOMATIC RENEWAL. This Agreement shall become effective upon acceptance by FINOVA and shall continue in full force and effect for a term ending May 21, 2000 (the "Renewal Date") and shall be automatically renewed for successive ONE (1) year periods thereafter, unless sooner terminated pursuant to terms hereof. Either party may terminate this Agreement on the Renewal Date or on any anniversary of the Renewal date by giving the other party at least ninety (90) days prior written notice by registered or certified mail, return receipt requested. Notwithstanding the foregoing, FINOVA shall have the right to terminate this Agreement immediately and without notice upon the occurrence of an Event of Default. 2.9 EFFECT OF TERMINATION. On the date of termination, all Obligations shall become immediately due and payable without notice or demand. No termination of this Agreement, however, shall relieve or discharge Borrower of Borrower's duties, Obligations, and covenants hereunder, and FINOVA's continuing security interest in the Collateral shall remain in effect, until all Obligations have been fully discharged and FINOVA's obligation to provide advances hereunder is terminated. If Borrower has sent a notice of termination pursuant to the provisions of SECTION 2.10, but fails to pay all Obligations as of the date set in said notice, then FINOVA may, but shall not be required to, renew this Agreement for an additional term of one (1) years. 2.10 EARLY TERMINATION BY BORROWER. Notwithstanding the provisions of SECTION 2.8 which allow termination of this Agreement by Borrower only on the Renewal Date and certain anniversaries thereof, at any time subsequent to the expiration of the initial year of this Agreement, Borrower has the option, on ninety (90) days prior written notice to FINOVA, to terminate this Agreement on a date other than an anniversary of the effective date by paying to FINOVA, in cash, the Obligations together with all accrued and unpaid interest and expense and a prepayment penalty of Fifteen Thousand Dollars ($15,000.00). 2.11 TERMINATION UPON EVENT OF DEFAULT. If FINOVA terminates this Agreement upon the occurrence of an Event of Default, in view of the impracticability and extreme difficulty of ascertaining actual damages and by mutual agreement of the parties as to a reasonable calculation of FINOVA's lost profits as a result thereof, Borrower shall pay to FINOVA upon the effective date of such termination, a fee ("Early Termination Fee") in an amount equal to THE MINIMUM INTEREST DUE FOR THE REMAINING TERM OF THE AGREEMENT. The Early Termination Fee shall be presumed to be the amount of damages sustained by FINOVA as the result of the early termination and Borrower agrees that it is reasonable under the circumstances currently existing. The Early Termination Fee provided for in this SECTION 2.11 shall be deemed included in the Obligations. 3. SECURITY 3.1 GRANT OF SECURITY INTEREST. Borrower hereby grants to FINOVA a continuing security interest in all presently existing and hereafter acquired or arising Collateral in order to secure prompt repayment of any and all Obligations and in order to secure prompt performance by Borrower of each of its covenants and duties under the Loan Documents. FINOVA's security interest in the Collateral shall attach to all Collateral without further act on the part of FINOVA or Borrower. 7 3.2 NEGOTIABLE COLLATERAL. In the event that any Collateral, including proceeds, is evidenced by or consists of Negotiable Collateral, Borrower shall, immediately upon the request of FINOVA, endorse and assign such Negotiable Collateral to FINOVA and deliver physical possession of such Negotiable Collateral to FINOVA. 3.3 COLLECTION OF ACCOUNTS, NEGOTIABLE COLLATERAL. FINOVA or FINOVA's designee may, at any time: (a) notify customers or account debtors of Borrower that the Accounts or Negotiable Collateral have been assigned to FINOVA or that FINOVA has a security interest herein; (b) require Borrower to establish a lock-box or other restricted account satisfactory to FINOVA for the collection of Accounts; and (c) collect the accounts and Negotiable Collateral directly and charge the collection costs and expenses to Borrower's loan account; but, unless and until FINOVA does so or gives Borrower other written instruction, Borrower shall collect all Accounts and Negotiable Collateral for FINOVA, receive in trust all payments thereon as FINOVA's trustee, and immediately deliver said payments to FINOVA in their original form as received from the account debtor. 3.4 DELIVERY OF ADDITIONAL DOCUMENTATION REQUIRED. Borrower shall execute and deliver to FINOVA, prior to or concurrently with Borrower's execution and delivery of this Agreement and at any time thereafter at the request of FINOVA, all financing statements, continuation financing statements, fixture filings, security agreements, assignments, endorsements of certificates of title, applications for title, affidavits, reports, notices, schedules of accounts, letters of authority, and all other documents that FINOVA may reasonably request, in form satisfactory to FINOVA, to perfect and maintain perfected FINOVA security interests in the Collateral and in order to fully consummate all of the transactions contemplated under the Loan Documents. 3.5 POWER OF ATTORNEY. Borrower hereby irrevocably makes, constitutes, and appoints FINOVA (and any of FINOVA'S officers, employees, or agents designated by FINOVA) as Borrower's true and lawful attorney, with power to: (a) sign the name of Borrower on any of the documents described in SECTION 3.4 or on any other similar documents to be executed, recorded, or filled in order to perfect or continue perfected FINOVA's security interest in the Collateral; (b) sign Borrower's name on any invoice or bill of lading relating to any Account, drafts against account debtors, schedules and assignments of Accounts, verifications of Accounts, and notices to account debtors; (c) send requests for verification of Accounts; (d) endorse Borrower's name on any checks, notes, acceptances, money orders, drafts, or other forms of payment or security that may come into FINOVA's possession; (e) notify the post office authorities to change the address for delivery of Borrower's mail to an address designated by FINOVA, to receive and open all mail addressed to Borrower, and to retain all mail relating to the Collateral and forward all other mail to Borrower; (f) make, settle, and adjust all claims under Borrower's policies of insurance and make all determinations and decisions with respect to such policies of insurance; and (g) settle and adjust disputes and claims respecting the accounts directly with account debtors, for amounts and upon terms which FINOVA determines to be reasonable, and FINOVA may cause to be executed and delivered any documents and releases which FINOVA determines to be necessary. The appointment of FINOVA as Borrower's attorney, and each and every one of FINOVA's rights and powers, being coupled with an interest, is irrevocable until all of the Obligations have been fully repaid and performed and FINOVA's obligation to provide advances hereunder is terminated. 3.6 RIGHT TO INSPECT. FINOVA (through any of its officers, employees, or agents) shall have the right, from time to time hereafter, during Borrower's usual business hours, or during the usual business hours of any third party having control over the records of Borrower, to inspect Borrower's books and to check and test the Collateral in order to verify Borrower's financial condition or the amount, quality, value, condition of, or any other matter relating to, the Collateral. 4. CONDITIONS OF CLOSING 4.1 INITIAL ADVANCE. Borrower agrees and acknowledges that FINOVA has no obligation to make the initial advance hereunder until such time as FINOVA is fully satisfied that (a) it has all the 8 loan and related documents, properly authorized and executed by Borrower, (b) it has a first secured position in the Collateral, and (c) all other closing conditions reasonably required by FINOVA have been met. 4.2 SUBSEQUENT ADVANCES. The obligation of FINOVA to make any subsequent advance hereunder shall be subject to the further conditions precedent that, on and as of the date of such advance: (a) the representations and warranties of Borrower set forth in this Agreement shall be accurate, before and after giving effect to such advance and to the application of any proceeds thereof; (b) no Event of Default and no event which, with notice or passage of time or both, would constitute an Event of Default has occurred and is continuing, or would result from such advance or from the application of any proceeds thereof; (c) no material adverse change has occurred in the Borrower's business, operations, or financial condition, or in the condition of the Collateral or other assets of Borrower or in the prospect of repayment of the Obligations; and (d) FINOVA shall have received such other approvals, opinions or documents as FINOVA shall reasonably request. 5. REPRESENTATION AND WARRANTIES Borrower represents and warrants as follows: 5.1 NO PRIOR ENCUMBRANCES. Borrower has good and indefeasible title to the Collateral, free and clear of liens, claims, security interest, or encumbrances (except as held by FINOVA and except as may be specifically consented to, in advance and in writing, by FINOVA). 5.2 BONA FIDE ACCOUNTS. The Accounts are, and at all times hereafter shall be, bona fide existing obligations created by the sale and delivery of Inventory or the rendition of services to account debtors in the ordinary course of Borrower's business, unconditionally owed to Borrower without defenses, disputes, offsets, counterclaims, or rights of return or cancellation. The property giving rise to such Accounts has been delivered to the account debtor or to the account debtor's agent for immediate shipment to and unconditional acceptance by the account debtor. Borrower has not, and at all times hereafter, shall not have, received notice of actual or imminent bankruptcy, insolvency, or financial embarrassment of any account debtor at the time an Account due from such account debtor is assigned to FINOVA. 5.3 MERCHANTABLE INVENTORY AND INVENTORY RECORDS. All Inventory is now and at all times hereafter shall be of good and marketable quality, free from defects. Borrower now keeps and hereafter at all times shall keep, correct and accurate records itemizing and describing the kind type, quality and quantity of the Inventory, and Borrower's cost therefor. 5.4 LOCATION OF INVENTORY AND EQUIPMENT. The Inventory and Equipment is not now and shall not at any time hereafter be stored with a bailee, warehouseman, or similar party without FINOVA's prior written consent. Borrower shall keep the Inventory and Equipment only at the following location(s): 428, 1434, 1444, 1460, 1470, 1500, AND 1516 SANTA ANITA AVENUE, SOUTH EL MONTE, CA 91733 AND 1425 AND 1427 LIDCOMBE AVENUE, SOUTH EL MONTE, CA 91733 5.5 LOCATION OF PRINCIPAL PLACE OF BUSINESS/CHIEF EXECUTIVE OFFICE/RESIDENCE. The chief executive office or residence of Borrower is at the address indicated in the first paragraph of this Agreement and Borrower covenants and agrees that it will not, without thirty (30) days prior written notification to FINOVA, relocate such principal place of business, chief executive office, or residence. 5.6 DUE ORGANIZATION QUALIFICATION. If Borrower is a corporation it is and shall at all times hereafter be duly organized and existing and in good standing under the laws of the state of its incorporation and qualified and licensed to do business in, and in good standing in, any state in which the conduct of its business or its ownership of property requires that it be so qualified; if Borrower is a partnership, or limited liability company, it is and shall at all times hereafter be duly organized and existing 9 and in good standing under the laws of the state of its organization and qualified and licensed to do business in, and in good standing in, any state in which the conduct of its business or the ownership of property requires that its be so qualified. 5.7 DUE AUTHORIZATION; NO CONFLICT. The execution, delivery, and performance of the Loan Documents are within Borrower's corporate, partnership, trust, limited liability company or personal powers, as the case may be, have been duly authorized, and are not in conflict with nor constitute a breach of any provision contained in Borrower's Articles or Certificate of Incorporation, By-laws, or any operating agreement, partnership or trust agreement pertaining to Borrower, nor will they constitute an event of default under any material agreement to which Borrower is now or may hereafter become a party. 5.8 LITIGATION. There are no actions or proceedings pending by or against Borrower before any court or administrative agency and Borrower does not have knowledge or belief of any pending, threatened, or imminent litigation, governmental investigations, or claims, complaints, actions, or prosecutions involving Borrower or any guarantor of the Obligations, except for ongoing collection matters in which Borrower is the plaintiff. If any of the forgoing arises during the term of this Agreement, Borrower shall promptly notify FINOVA in writing. 5.9 NO MATERIAL ADVERSE CHANGE IN FINANCIAL STATEMENTS. All financial statements relating to Borrower or any guarantor of the Obligations which have been or may hereafter be delivered by Borrower to FINOVA have been prepared in accordance with GAAP and fairly present Borrower's financial condition as of the date thereof and Borrower's result of operations for the period then ended. There has been no material adverse change in the financial condition of Borrower or any guarantor since the date of the most recent of such financial statements submitted to FINOVA. 5.10 SOLVENCY. Borrower is now and shall be at all times hereafter solvent and able to pay its debts (including trade debts) as they mature. 5.11 ERISA. None of Borrower, any ERISA Affiliate, or any plan is or has been in violation of any of the provisions of ERISA, any of the qualification requirements of IRC Section 401(a), or any of the published interpretations there under. No notice of intent to terminate a Plan has been filed under Section 4041 of ERISA, nor has any Plan been terminated under Section 4041(e) of ERISA. The PBGC has not instituted proceedings to terminate, or appoint a trustee to administer, a plan an no event has occurred of condition exists which might constitute grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Plan. Neither Borrower nor any ERISA Affiliate would be liable for any amount pursuant to Section 4062, 4063, or 4064 of ERISA if all Plans terminated as of the most recent valuation dates of such Plans. Neither Borrower nor any ERISA Affiliate have: withdrawn from a "multiple employer plan" during a plan year for which it was a substantial employer, as defined in Section 4001(a)(2) of ERISA; or failed to make a payment to a plan required under Section 302(f)(1) of ERISA such that security would have to be provided pursuant to Section 307 of ERISA. No lien upon the assets of Borrower has arisen with respect to any plan. No Prohibited Transaction or Reportable Event has occurred with respect to Plan. Neither Borrower nor any ERISA Affiliate has incurred any withdrawal liability with respect to any Multiemployer Plan. Borrower and each ERISA Affiliate have made all contributions required to be made by them to any plan or Multiemployer Plan when due. There is no accumulated funding deficiency in any Plan, whether or not waived. 5.12 ENVIRONMENTAL CONDITION. None of Borrower's properties or assets has ever been used by Borrower or, to the best of Borrower's knowledge, by previous owners or operators in the disposal of, or to produce, store, handle, treat, release, or transport, any hazardous waste or hazardous substance. None of Borrower's properties or assets has ever been designed or identified in any manner pursuant to any environmental protection statute as a hazardous waste or hazardous substance disposal site, or a candidate for closure pursuant to any environmental protection statute. No lien arising under any environmental protection statute has attached to any revenues or to any real personal property owned by Borrower. Borrower has not received a summons, citation, notice, or directive from the Environmental Protection 10 Agency or any other federal or state governmental agency concerning any action or omission by Borrower resulting in the releasing, or otherwise disposing of hazardous waste or hazardous substances into the environment. 5.13 RELIANCE BY FINOVA; CUMULATIVE. Each warranty, representation, and agreement contained in this Agreement shall be automatically deemed repeated with each advance and shall be conclusively presumed to have been relied on by FINOVA regardless of any investigation made or information possessed by FINOVA. The warranties, representations, and agreements set forth herein shall be cumulative and in addition to any and all other warranties, representations, and agreements which Borrower shall now or hereafter give, or cause to be given, to FINOVA. 5.14 YEAR 2000 REPRESENTATIONS & WARRANTIES. Borrower has taken all action necessary to assure that there will be no material adverse change to Borrower's business by reason of the advent of the year 2000, including without limitation that all computer-based systems, embedded microchips and other processing capabilities effectively recognize and process dates after April 1, 1999. 6. COVENANTS 6.1 AFFIRMATIVE COVENANTS. Borrower covenants and agrees that, so long as any credit hereunder shall be available and until payment in full of the Obligations, and unless FINOVA shall otherwise consent in writing, Borrower shall do all of the following: 6.1.1 ACCOUNTING SYSTEM. Borrower at all times hereafter shall maintain a standard and modern system of accounting in accordance with GAAP with ledger and account cards or computer tapes, disks, printouts, and records pertaining to the Collateral which contain information as may from time to time be requested by FINOVA. Borrower shall also keep proper books of Accounts showing all Sales, claims, and allowances on its inventory. 6.1.2 COLLATERAL REPORTS. Borrower shall, deliver to FINOVA, no later than the tenth (10th) day of each month during the term of this Agreement, a detailed aging, by total, of the accounts, a reconciliation statement, and a summary aging, by vendor, of all accounts payable and any book overdraft. Original sales invoices evidencing daily sales shall be mailed by Borrower to each account debtor with a copy to FINOVA, and, at FINOVA's direction, the invoices shall indicate on their face that the Account has been assigned to FINOVA and that all payments are to be made directly to FINOVA. Borrower shall deliver to FINOVA, as FINOVA may from time to time require, collection reports, sales journals, invoices, original delivery receipts, customer's purchase orders, shipping instructions, bills of lading and other documentation respecting shipment arrangements. Absent such a request by FINOVA, copies of all such documentation shall be held by Borrower as custodian for FINOVA. 6.1.3 ASSIGNMENTS OF ACCOUNTS. Borrower shall provide FINOVA with schedules describing all Accounts and shall execute and deliver to FINOVA assignments of all Accounts. Borrower's failure to execute and deliver such schedules or assignments shall not affect or limit FINOVA's security interest or other rights in and to the Accounts. 6.1.4 FINANCIAL STATEMENTS, REPORTS, CERTIFICATES. Borrower agrees to deliver to FINOVA: (a) as soon as available, but in any event within forty-five (45) days after the end of each fiscal quarter during each of Borrower's fiscal years, a company prepared balance sheet, income statement and cash flow statement covering Borrower's operations during such period; and (b) as soon as available, but in any event within one hundred twenty (120) days after the end of each of Borrower's fiscal years, financial statements of Borrower for each such fiscal year, reviewed by independent certified public accountants acceptable to FINOVA and certified, without any qualifications, by such accountants to have been prepared in accordance with GAAP, consistently applied, together with a certificate of such accountants addressed to FINOVA stating that such accountants do not have knowledge of the existence of any event or condition constituting an Event of Default. Such reviewed financial statements shall include a balance sheet, profit 11 and loss statement, and cash flow statement, and such accountants' letter to management. Borrower shall have issued written instructions to its independent certified public accountants, authorizing them to communicate with FINOVA and to release to FINOVA whatever financial information concerning Borrower that FINOVA may request. If Borrower is a parent company of one or more subsidiaries, or affiliates, or is a subsidiary or affiliate of another company, then, in addition to the financial statement referred to above, Borrower agrees to deliver financial statements prepared on a consolidating basis so as to present Borrower and each such related entity separately, and on a consolidated basis. Together with the above, Borrower shall also deliver to FINOVA any other report reasonably requested by FINOVA relating to the Collateral and the financial condition of Borrower. Each month Borrower shall deliver to FINOVA a certificate signed by its chief financial officer to the effect that: (a) all reports, statements, or computer prepared information of any kind or nature delivered or caused to be delivered to FINOVA hereunder have been prepared in accordance with GAAP, consistently applied and fully and fairly present the financial condition of Borrower; (b) Borrower is in timely compliance with all representations, warranties, and covenants hereunder; and (c) on the date of delivery of such certificate to FINOVA there does not exist any condition or event which constitutes an Event or Default. Borrower hereby irrevocably authorizes and directs all auditors, accountants, or other third parties to deliver to FINOVA, at Borrower's expense, copies of Borrower's financial statements, papers related thereto, and other accounting records of any nature in their possession, and to disclose to FINOVA any information they may have regarding Borrower's business affairs and financial conditions. 6.1.5 TAX RETURNS, RECEIPTS. Borrower agrees to deliver to FINOVA copies of Borrower's future federal income tax returns and any amendments thereto, within thirty (30) days of the filing thereof with the Internal Revenue Service. 6.1.6 GUARANTOR REPORTS. Borrower agrees to cause all guarantors of any of the Obligations to deliver their annual financial statements and copies of all federal income tax returns as soon as the same are available and in any event no later than thirty (30) days after the same are required to be filed by law. 6.1.7 DESIGNATION OF INVENTORY AND RETURNS. Borrower shall now and from time to time hereafter, but not less frequently than monthly, execute and deliver to FINOVA a designation of Inventory specifying Borrower's cost and the wholesale market value of Borrower's raw materials, work in process, and finished goods, and further specifying such other information as FINOVA may reasonably request. Returns and allowances, if any, as between Borrower and its account debtors, shall be on the same basis and in accordance with the usual customary practices of Borrower, as they exist at the time of the execution and delivery of this Agreement. If at any time prior to the occurrence of an Event of Default, any account debtor returns any Inventory to Borrower, Borrower shall promptly determine the reason for such return and, if Borrower accepts such return, issue a credit memorandum (with a copy to be sent to FINOVA) in the appropriate amount to such account debtor. Borrower shall promptly notify FINOVA of all returns and recoveries and of all disputes and claims. 6.1.8 TITLE TO EQUIPMENT. Upon FINOVA's request, Borrower shall immediately deliver to FINOVA, properly endorsed, any and all evidences of ownership of, certificates of title, or applications for title to any items of Equipment. 6.1.9 MAINTENANCE OF EQUIPMENT. Borrower shall keep and maintain the Equipment in good operating condition and repair, make all necessary replacements thereto so that the value and operating efficiency thereof shall at all times be maintained and preserved. Borrower shall not permit any item of Equipment to become a fixture to real estate or an possession to other property, and the Equipment is now and shall at all times remain personal property. 12 6.1.10 TAXES. All assessments and taxes, whether real, personal, or otherwise, due or payable by, or imposed, levied, or assessed against Borrower or any of its property have been paid, and shall hereafter be paid in full, before delinquency or before the expiration of any extension period. Borrower shall make due and timely payment or deposit of all federal, state, and local taxes, assessments, or contributions required of it by law, and will execute and deliver to FINOVA, on demand, appropriate certificates attesting to the payment or deposit thereof. Borrower will make timely payment or deposit of all tax payments and withholding taxes required of it by applicable laws, including, but not limited to, those laws concerning F.I.C.A., and F.U.T.A., state disability, and local, state, and federal income taxes, and will, upon request, furnish FINOVA with proof satisfactory to FINOVA indicating that Borrower has made such payments or deposits. 6.1.11 INSURANCE. (a) Borrower, at its expense, shall keep the Collateral insured against loss of damage by fire, theft, explosion, sprinklers, and all other hazards and risks, and in such amounts, as ordinarily insured against by other owners in similar businesses. Borrower shall also maintain business interruption, public liability, product liability, and property damage insurance relating to Borrower's ownership and use of the Collateral. (b) All such policies of insurance shall be in such form, with such companies, and on such amounts as satisfactory to FINOVA. All such policies of insurance (except those of public liability and property damage) shall contain a 438BFU lender's loss payable endorsement, or an equivalent endorsement in a form satisfactory to FINOVA, showing FINOVA as sole loss payee thereof, and shall contain a waiver of warranties, and shall specify that, the insurer must give at least ten (10) days notice to FINOVA before canceling its policy for any reason. Borrower shall deliver to FINOVA certified copies of such policies of insurance and evidence of the payments of all premiums therefor. All proceeds payable under any such policy shall be payable to FINOVA to be applied on account of the Obligations. 6.1.12 FINOVA EXPENSES. Borrower shall immediately and without demand reimburse FINOVA for all sums expended by FINOVA which constitute FINOVA Expenses and Borrower hereby authorizes and approves all advances and payments by FINOVA for items constituting FINOVA Expenses. 6.1.13 YEAR 2000 COVENANTS. Borrower shall take all action necessary to assure that there will be no material adverse change to Borrower's business by reason of the advent of the year 2000, including without limitation that all computer-based systems, embedded microchips and other processing capabilities effectively recognize and process dates after April 1, 1999. At FINOVA's request, Borrower shall provide to FINOVA assurance reasonably acceptable to FINOVA that Borrower's computer-based systems, embedded microchips and other processing capabilities are year 2000 compatible. 6.2 NEGATIVE COVENANTS. Borrower covenants and agrees that, so long as any credit hereunder shall be available and until payment in full of the Obligations, Borrower will not do any of the following without FINOVA's prior written consent: 6.2.1 EXTRAORDINARY TRANSACTIONS AND DISPOSAL OF ASSETS. Enter into any transaction not in the ordinary and usual course of Borrower's business, including but not limited to, the sale, lease, or other disposition of, moving, relocation, or transfer, whether by sale or otherwise, of any of Borrower's assets (other than sales of Inventory in the ordinary and usual course of Borrower's business as presently conducted), the incurrence of any debts outside the ordinary and usual course of Borrower's business except for renewals or extensions of existing debts, or the making of any advance or loan except in the ordinary course of business as presently conducted, or the suspension of Borrower's business. 6.2.2 CHANGE NAME. Change Borrower's name, business structure, or identity, or add any new fictitious name. 13 6.2.3 MERGE, ACQUIRE. Acquire, merge, or consolidate with or into any other business organization. 6.2.4 GUARANTEE. Guarantee or otherwise become in any way liable with respect to the obligations of any third party except by endorsement of instruments or items of payment for deposit to the account of Borrower of which are transmitted or turned over to FINOVA. 6.2.5 RESTRUCTURE. Make any change in Borrower's financial structure or in any of its business operations, or change the date of its fiscal year. 6.2.6 PREPAYMENT. Prepay any existing indebtedness owing to any third party. 6.2.7 CHANGE OF OWNERSHIP. Cause, permit, or suffer any change, direct or indirect, in Borrower's ownership in excess of ten percent (10%). 6.2.8 CAPITAL EXPENDITURES. Make any plant or fixed capital expenditure, or any commitment therefor, or purchase or lease any real or personal property or replacement equipment subject to a purchase money security interest, trust deed or lease, in excess of ONE HUNDRED FIFTY THOUSAND AND 00/100 Dollars ($150,000.00) for any individual transaction or where the aggregate amount of such transactions, in any fiscal year, is in excess of ONE HUNDRED FIFTY THOUSAND AND 00/100 Dollars ($150,000.00). 6.2.9 CONSIGNMENTS. Consign any Inventory, sell any goods on bill and hold, or other unusual terms of sale. 6.2.10 DISTRIBUTIONS. Make any distribution or declare or pay any dividends (in cash or in stock) on, or purchase, acquire, redeem, or retire any of Borrower's capital stock, of any class, whether now or hereafter outstanding. 6.2.11 ACCOUNTING METHODS. Modify or change its method of accounting or enter into, modify, or terminate any agreement presently existing, or at any time hereafter entered into with any third party accounting firm or service bureau for the preparation or storage of Borrower's accounting records without said accounting firm or service bureau agreeing to provide FINOVA information regarding the Collateral or Borrower's financial condition. Borrower waives the right to assert a confidential relationship, if any, it may have with any accounting firm or service bureau in connection with any information requested by FINOVA pursuant to or in accordance with this Agreement, and agrees that FINOVA may contact directly any such accounting firm or service bureau in order to obtain such information. 6.2.12 INVESTMENTS. Directly or indirectly make or any beneficial interest in (including stock, partnership interest, or other securities of), or make any loan, advance, or capital contribution to, any corporation, association, person, or entity, in excess on One Hundred Fifty Thousand and 00/100 Dollars ($150,000.00). 6.2.13 TRANSACTIONS WITH AFFILIATES. Borrower will not directly or indirectly enter into or permit to exist any material transaction with any person or entity controlling, controlled by, or under common control (whether by contract, ownership of voting securities, or otherwise) with Borrower except for transactions which are in the ordinary course of Borrower's business, upon fair and reasonable terms and which are fully disclosed to FINOVA and no less favorable to Borrower than would be obtained in an arm's length transaction with a non-affiliated person or entity. 14 7. DEFAULTS AND REMEDIES 7.1 DEFAULTS. Any one or more of the following events shall constitute an Event of Default by Borrower under this Agreement: (a) If Borrower fails to pay when due and payable or when declared due and payabl, any portion of the Obligations (whether of principal, interest (including any interest which, but for the provisions of the United States Bankruptcy Code, would have accrued on such accounts), fees and charges due FINOVA, taxes, reimbursement of FINOVA Expenses, or otherwise); (b) If Borrower fails or neglects to perform, keep, or observe any term, provision, condition, covenant, or agreement contained in this Agreement, in any of the Loan Documents, or in any other present or future agreement between Borrower and FINOVA; (c) If there is a material impairment of the prospect of repayment of any portion of the Obligations owing to FINOVA or a material impairment of the value or priority of FINOVA's security interests in the Collateral; (d) If any material portion of Borrower's assets is attached, seized, subjected to a writ or distress warrant, or is levied upon, or comes into the possession of any judicial officer or assignee; (e) If an Insolvency Proceeding is commenced by Borrower; (f) If an Insolvency Proceeding is commenced against Borrower; (g) If Borrower is enjoined, restrained, or in any way prevented by court order from continuing to conduct all or any material part of its business affairs; (h) If a notice of lien, levy, or assessment is filed or recorded with respect to any of Borrower's assets by the United States Government, or any department, agency, or instrumentality thereof, or by any state, county, municipal, or other governmental agency, or if any taxes or debts owing at any time hereafter to any one or more of such entities becomes a lien, whether choate or otherwise, upon any of Borrower's assets and the same is not paid on the payment date thereof; (i) If a judgment or other claim becomes a lien or encumbrance upon any material portion of Borrower's assets; (j) If there is default in any material agreement to which Borrower is a party with third parties resulting in a right by such third parties, whether or not exercised, to accelerate the maturity of Borrower's indebtedness; (k) If Borrower makes any payment on account of indebtedness which has been subordinated to the Obligations except to the extent such payment is allowed under any subordination agreement entered into with FINOVA; (l) If any misstatement or misrepresentation exists now or hereafter in any warranty, representation, statement, or report made to FINOVA by Borrower or any officer, employee, agent, or director of Borrower, or if any such warranty or representation is withdrawn by any officer or director; (m) If any guaranty of the Obligations is limited or terminated by operation of law or by the guarantor thereunder, or any guarantor becomes the subject of an Insolvency Proceeding; 15 (n) If a Prohibited Transaction or Reportable Event shall occur with respect to a Plan which could have a material adverse effect on the financial condition of Borrower; if any lien upon the assets of Borrower in connection with any plan shall arise; if Borrower or any ERISA Affiliate shall completely or partially withdraw from a Multiemployer Plan or a Multiple Employer Plan of which Borrower or such ERISA Affiliate was a substantial employer, and such withdrawal could, in the opinion of FINOVA, have a material adverse effect on the financial condition of Borrower; if Borrower or any of its ERISA Affiliates shall fail to make full payment when due of all amounts which Borrower or any of its ERISA Affiliates may be required to pay to any Plan or any Multiemployer plan as one or more contributions thereto; if Borrower or any of its ERISA Affiliates creates or permits the creation of any accumulated funding deficiency, whether or not waived; or upon the voluntary or involuntary termination of any Plan which termination could, in the opinion of FINOVA, have a material adverse effect on the financial condition of Borrower, or Borrower shall fail to notify FINOVA promptly and in any event within ten (10) days of the occurrence of any event which constitutes an Event of Default under this clause or would constitute such an Event of Default upon exercise of FINOVA's judgment; or (o) If any writing, document, aging, certificate or other evidence of the Accounts or Inventory shall be materially incomplete, incorrect, or misleading at the time the same is furnished to FINOVA. 7.2 REMEDIES. Upon the occurrence of an Event of Default FINOVA may, at its election, without notice of its election and without demand, do any one or more of the following, all of which are authorized by Borrower; (a) Declare all Obligations, whether evidenced by this Agreement, by any of the other Loan Documents, or otherwise, immediately due and payable; (b) Cease advancing money or extending credit to or for the benefit of Borrower under this Agreement, under any of the Loan Documents, or under any other agreement between Borrower and FINOVA; (c) Terminate this Agreement and any of the other Loan Documents as to any future liability or Obligation of FINOVA, but without affecting FINOVA's rights and security interest in the Collateral and without affecting the Obligations; (d) Settle or adjust disputes and claims directly with account debtors for amounts and upon terms which FINOVA considers advisable, and in such cases, FINOVA will credit Borrower's loan account with only the net amounts received by FINOVA in payment of such disputed Accounts, after deducting all FINOVA Expenses incurred or expended in connection therewith; (e) Cause Borrower to hold all returned Inventory in trust for FINOVA, segregate all returned Inventory from all other property of Borrower or in Borrower's possession and conspicuously label said returned Inventory as the property of FINOVA; (f) Without notice to or demand upon Borrower or any guarantor, make such payments and do such acts, as FINOVA considers necessary or reasonable to protect its security interest in the Collateral. Borrower agrees to assemble the Collateral if FINOVA so requires, and to make the Collateral available to FINOVA as FINOVA may designate. Borrower authorizes FINOVA to enter the premises where the Collateral is located, to take and maintain possession of the Collateral, or any part of it, and to pay, purchase, contest, or compromise any encumbrance, charge, or lien which in FINOVA's determination appears to be prior or superior to its security interest and to pay all expenses incurred in connection therewith. With respect to any of Borrower's owned premises, Borrower hereby grants FINOVA a license to enter into possession of such premises and to occupy the same, without charge, for up to ninety (90) days in order to exercise any of FINOVA's rights or remedies provided herein, at law, in equity, or otherwise; 16 (g) Set off and apply any and all balances and deposits held by, or indebtedness at any time owing to or for the credit or the account of Borrower by FINOVA without notice to Borrower (such notice being expressly waived); (h) Ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell (in the manner provided for herein) the Collateral. FINOVA is hereby granted a license or other right to use, without charge, Borrower's labels, patents, copyrights, rights of use of any name, trade secrets, trade names, trademarks, service marks, and advertising matter, or any property of a similar nature, as it pertains to the Collateral, in completing production of advertising for sale, and selling any Collateral and Borrower's rights under all licenses and all franchise agreements shall inure to FINOVA's benefit; (i) Sell the Collateral at either a public or private sale, or both, by way of one or more contracts or transactions, for cash or on terms, in such manner and at such places (including Borrower's premises) as FINOVA determines is commercially reasonable. It is not necessary that the Collateral be present at any such sale; (j) FINOVA shall give notice of the disposition of the Collateral as follows: (1) FINOVA shall give the Borrower and each holder of a security interest in the Collateral who has filed with FINOVA a written request for notice, a notice in writing of the time and place of public sale, or, if the sale is a private sale or some other disposition other than a public sale is to be made of the Collateral, then the time on or after which the private sale or other disposition is to be made; (2) The notice shall be personally delivered or mailed, postage prepaid, to Borrower as provided in Section 9.3 of this Agreement, at least five (5) calendar days before the date fixed for the sale, or at least five (5) calendar days before the date on or after which the private sale or other disposition is to be made, unless the Collateral is perishable or threatens to decline speedily in value. Notice to persons other than Borrower claiming an interest in the Collateral shall be sent to such addresses as they have furnished to FINOVA; (3) If the sale is to be a public sale, FINOVA shall also give notice of the time and place by publishing a notice one time at least five (5) calendar days before the date of the sale in a newspaper of general circulation in the county in which the sale is to be held; (k) FINOVA may credit bid and purchase at any public sale; and (l) Any deficiency, which exists after disposition of the Collateral, as provided above will be paid immediately by Borrower. Any excess will be returned to Borrower, without interest and subject to the rights of third parties, by FINOVA. 7.3 REMEDIES CUMULATIVE. FINOVA's rights and remedies under this Agreement, the Loan Documents, and all other agreements shall be cumulative. FINOVA shall have all other rights and remedies not inconsistent herewith as provided under the Code, by law, or in equity. No exercise by FINOVA or one right or remedy shall be deemed an election, and no waiver by FINOVA of any Event of Default on Borrower's part shall be deemed a continuing waiver. No delay by FINOVA shall constitute a waiver, election, or acquiescence by it. 8. EXPENSES AND INDEMNITIES 8.1 If Borrower fails to pay any monies (whether taxes, assessments, insurance premiums, or otherwise) due to third persons or entities, or fails to make any deposits or furnish any required proof of payment or deposit, all as required under the terms of this Agreement, then, to the extent that FINOVA determines that such failure by Borrower could have a material adverse effect on FINOVA's 17 interests in the Collateral, in its discretion and without prior notice to Borrower, FINOVA may do any or all of the following: (a) make payment of the same or any part thereof; (b) set up such reserves in Borrower's loan account as FINOVA deems necessary to protect FINOVA from the exposure created by such failure; or (c) obtain and maintain insurance policies of the type discussed in SECTION 6.1.11 of this Agreement, and take any action with respect to such policies as FINOVA deems prudent. Any amounts paid or deposited by FINOVA shall constitute FINOVA Expenses, shall be immediately charged to Borrower's loan account and become additional Obligations, shall bear interest at the then applicable rate herein above provided, and shall be secured by the Collateral. Any payments made by FINOVA shall not constitute an agreement by FINOVA to make similar payments in the future or a waiver by FINOVA of any Event of Default under this Agreement. FINOVA need not inquire as to, or contest the validity of, any such expense, tax, security interest, encumbrance, or lien and the receipt of the usual official notice for the payment thereof shall be conclusive evidence that the same was validly due and owing. 9. MISCELLANEOUS 9.1 DEMAND; PROTEST; ETC. Borrower waives demand, protest, notice of protest, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees at any time held by FINOVA on which Borrower may in any way be liable. 9.2 FINOVA'S LIABILITY FOR INVENTORY OR EQUIPMENT. So long as FINOVA complies with its obligations, if any, under Section 9207 of the Code; FINOVA shall not in any way or manner be liable or responsible for: (a) the safekeeping of the Collateral; (b) any loss or damage thereto occurring or arising in any manner or fashion from any cause; (c) any diminution in the value thereof; or (d) any act or default of any carrier, warehouseman, bailee, forwarding agency, or other person whomsoever. All risk of loss, damage or destruction of the Collateral shall be borne by Borrower. 9.3 NOTICES. Unless otherwise provided in this Agreement, all notices or demands by any party relating to this Agreement or any other agreement entered into in connection herewith shall be in writing and (except for financial statements and other informational documents which may be sent by first-class mail, postage prepaid) shall be personally delivered or sent by registered or certified mail, postage prepaid, return receipt requested, or by prepaid telex, TWX, telefacsimile, or telegram (with messenger delivery specified) to Borrower or to FINOVA, as the case may be, at its addresses set forth below: IF TO BORROWER: LEE PHARMACEUTICALS 1444 SANTA ANITA AVENUE SOUTH EL MONTE, CA 91733 ATTN: RONALD G. LEE, PRESIDENT If to FINOVA: FINOVA CAPITAL CORPORATION 355 South Grand Avenue, #2400 Los Angeles, California 90071 Attention: Farhad Motia, Vice President With a Copy to: Joseph R. D'Amore VP-Associate General Counsel FINOVA Capital Corporation 1850 N. Central Ave, Suite 1141 Phoenix, AZ 85002 18 The parties hereto may change the address at which they are to receive notices hereunder, by notice in writing in the foregoing manner given to the other. All notices or demands sent in accordance with this SECTION 9.3, other than notices by FINOVA in connection with Section 9504 or 9505 of the Code, shall be deemed received on the earlier of the date of actual receipt or three (3) calendar days after the deposit thereof in the mail. Borrower acknowledges and agrees that notices sent by FINOVA in connection with Sections 9504 or 9505 of the Code shall be deemed sent when deposited in the mail or transmitted by telefacsimile or other similar method set forth above. 9.4 CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER. THE VALIDITY OF THIS AGREEMENT, ITS CONSTRUCTION, INTERPRETATION, AND ENFORCEMENT AND THE RIGHTS OF THE PARTIES HERETO SHALL BE DETERMINED UNDER, GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF CALIFORNIA, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. THE PARTIES AGREE THAT ALL ACTIONS OR PROCEEDINGS ARISING IN CONNECTION WITH THIS AGREEMENT SHALL BE TRIED AND LITIGATED ONLY IN THE STATE AND FEDERAL COURTS LOCATED IN THE COUNTY OF LOS ANGELES, STATE OF CALIFORNIA OR AT THE SOLE OPTION OF FINOVA, IN ANY OTHER COURT IN WHICH FINOVA SHALL INITIATE LEGAL OR EQUITABLE PROCEEDINGS AND WHICH HAS SUBJECT MATTER JURISDICTION OVER THE MATTER IN CONTROVERSY. EACH OF BORROWER AND FINOVA WAIVES, TO THE EXTENT PERMITTED UNDER APPLICABLE LAW, ANY RIGHT EACH MAY HAVE TO ASSERT THE DOCTRINE OF FORUM NON CONVENIENS OR TO OBJECT TO VENUE TO THE EXTENT ANY PROCEEDING IS BROUGHT IN ACCORDANCE WITH THIS SECTION 9.4. BORROWER AND FINOVA HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF ANY OF THE LOAN DOCUMENTS OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREIN, INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS AND ALL OTHER COMMON LAW OR STATUTORY CLAIMS. BORROWER AND FINOVA EACH REPRESENT THAT IT HAS REVIEWED THIS WAIVER AND EACH KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. IN THE EVENT OF LITIGATION, A COPY OF THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 9.5 DESTRUCTION OF BORROWER'S DOCUMENTS. All documents, schedules, invoices, agings, or other papers delivered to FINOVA may be destroyed or otherwise disposed of by FINOVA three (3) months after they are delivered to or received by FINOVA, unless Borrower requests, in writing, the return of the said documents, schedules, invoices or other papers and makes arrangements, at Borrower's expense, for their return. 9.6 EFFECTIVENESS. This Agreement shall be binding and deemed effective when executed by Borrower and accepted and executed by FINOVA. 9.7 SUCCESSORS AND ASSIGNS. This Agreement shall bind and inure to the benefit of the respective successors and assigns of each of the parties; PROVIDED, HOWEVER, that Borrower may not assign this Agreement or any rights hereunder without FINOVA's prior written consent and any prohibited assignment shall be absolutely void. No consent to an assignment by FINOVA shall release Borrower from its Obligations. FINOVA may assign this Agreement and its rights and duties hereunder. FINOVA reserves the right to sell, assign, transfer, negotiate, or grant participations in all or any part of, or any interest in FINOVA's rights and benefits hereunder. In connection therewith, FINOVA may disclose all documents and information, which FINOVA now or hereafter may have relating to Borrower or Borrower's business. 9.8 SECTION HEADINGS. Heading and numbers have been set forth herein for convenience only. Unless the contrary is compelled by the context, everything contained in each paragraph applies equally to this entire Agreement. 19 9.9 INTERPRETATION. Neither this Agreement nor any uncertainty or ambiguity herein shall be construed or resolved against FINOVA or Borrower, whether under any rule of construction or otherwise. On the contrary, this Agreement has been reviewed by all parties and shall be construed and interpreted according to the ordinary meaning of the words used so as to fairly accomplish the purposes and intentions of all parties hereto. 9.10 PUBLICITY. FINOVA is hereby authorized by the undersigned to issue appropriate press releases and to cause a tombstone to be published announcing the consummation of this transaction. 9.11 SEVERABILITY OF PROVISONS. Each provision of this Agreement shall be severable from every other provision of this Agreement for the purpose of determining the legal enforceability of any specific provision. 9.12 AMENDMENTS IN WRITING. This Agreement cannot be changed or terminated orally. All prior agreements, understandings, representations, warranties, and negotiations, if any, are merged into this Agreement. 9.13 COUNTERPARTS. This agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute but one and the same Agreement. Borrower and FINOVA have executed this Agreement of FINOVA's place of business in Los Angeles, California. LEE PHARMACEUTICALS ------------------------ a California corporation ---------------------------- By: /s/ Ronald G. Lee ---------------------------- Ronald G. Lee, President FINOVA CAPITAL CORPORATION ---------------------------- a Delaware corporation ---------------------------- By: /s/ Farhad Motia ---------------------------- Farhad Motia, Vice President 20 EX-10.3 4 EXHIBIT 10.3 EXHIBIT 10.3 SECURED PROMISSORY NOTE $400,000.00 Los Angeles, California October 29, 1999 FOR VALUE RECEIVED, the undersigned hereby jointly and severally (if applicable) promises to pay to FINOVA CAPITAL CORPORATION, a Delaware Corporation, at 355 South Grand Avenue, Suite 2400, Los Angeles, California 90071, or at such other address as the holder may specify in writing, the principal sum of FOUR HUNDRED THOUSAND AND 00/100 Dollars ($400,000.00) plus interest as provided below. This note shall bear interest at the rate of 14.25% per annum, computed on the basis of a 360 day year for actual days elapsed. This rate is based upon the prime rate of interest of 8.25% the rate in effect as of this date. The prime rate of interest is the prime rate announced as being charged by Citibank, N.A. (or any successor thereto), New York, New York, from time to time. In the event the prime rate is from time to time hereafter changed, the rate of interest provided in this note shall be correspondingly changed. For each month the rate of interest charged under this note shall be based upon the average prime rate in effect during such month. In no event shall the rate of interest chargeable hereunder be less that 1.3% per month. Principal shall be payable in twelve equal monthly installments of Eleven Thousand One Hundred Eleven and 00/100 Dollars ($11,111.00) commencing December 1, 1999 and continue thereafter on the 1st day of each month, plus interest shall be payable monthly commencing December 1, 1999 and one final installment on May 21, 2000 equal to all principal outstanding together with all accrued and unpaid interest. This note is secured by that certain Loan and Security Agreement ("Agreement") dated October 29, 1999 and is subject to all of the terms and conditions thereof. In the event of default under the Agreement, including but not limited to, the failure to pay any installment of principal or interest hereunder when due, the holder of this note may, at its election and without notice to the undersigned, declare the entire balance hereof immediately due and payable. If any installment of principal or interest hereunder is not paid when due, the holder shall have the following rights in addition to the rights set forth in the preceding paragraph: (a) the right to add unpaid interest to principal and to have such amount thereafter bear interest as provided in this note, and (b) if any installment is more than ten days past due, the right to collect a charge equal to the greater of $15.00 or five percent of the delinquent payment. This charge is the result of a reasonable endeavor by the undersigned and the holder to estimate the holder's added costs and damages resulting from the undersigned's failure to timely make payments under this note; hence the undersigned agrees that the charge shall be presumed to be the amount of the damage sustained by the holder since it is extremely difficult to determine the actual amount necessary to reimburse the holder of such damages. If this note is not paid when due, the undersigned further promises to pay all costs of collection, foreclosure fees and reasonable attorneys' fees incurred by the holder whether or not suit is filed hereon. Provided the undersigned is not then in default hereunder or under any other agreement with the holder of this note, this note may be prepaid at any time prior to one year from the date hereof by paying the balance of principal owing plus all accrued and unpaid interest and charges, together with a prepayment charge of N/A on the amount prepaid. Presentment for payment, notice of dishonor, protest, and notice of protest are expressly waived. This note cannot be changed, modified, amended or terminated orally. WAIVER OF TRIAL BY JURY. THE UNDERSIGNED, TO THE EXTENT IT MAY LEGALLY DO SO, HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING ARISING UNDER OR WITH RESPECT TO THIS NOTE, OR IN ANY WAY CONNECTED WITH, OR RELATED TO, OR INCIDENTAL TO, THE DEALINGS OF THE PARTIES HERETO WITH RESPECT TO THIS NOTE OR THE TRANSACTIONS RELATED THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND IRRESPECTIVE OR WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. THE UNDERSIGNED, TO THE EXTENT IT MAY LEGALLY DO SO, HEREBY AGREES THAT ANY SUCH CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING SHALL BE DECIDED BY A COURT TRIAL WITHOUT A JURY AND THAT THE HOLDER OF THIS NOTE MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE UNDERSIGNED TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. IN WITNESS WHEREOF, this Note has been executed and delivered on the date first set forth above. LEE PHARMACEUTICALS a California corporation By: /s/ Ronald G. Lee --------------------------- Ronald G. Lee, President EX-10.4 5 EXHIBIT 10.4 EXHIBIT 10.4 SECURED PROMISSORY NOTE $400,000.00 Los Angeles, California October 29, 1999 FOR VALUE RECEIVED, the undersigned hereby jointly and severally (if applicable) promises to pay to FINOVA CAPITAL CORPORATION, a Delaware Corporation, at 355 South Grand Avenue, Suite 2400, Los Angeles, California 90071, or at such other address as the holder may specify in writing, the principal sum of FOUR HUNDRED THOUSAND AND 00/100 Dollars ($400,000.00) plus interest as provided below. This note shall bear interest at the rate of 14.25% per annum, computed on the basis of a 360 day year for actual days elapsed. This rate is based upon the prime rate of interest of 8.25% the rate in effect as of this date. The prime rate of interest is the prime rate announced as being charged by Citibank, N.A. (or any successor thereto), New York, New York, from time to time. In the event the prime rate is from time to time hereafter changed, the rate of interest provided in this note shall be correspondingly changed. For each month the rate of interest charged under this note shall be based upon the average prime rate in effect during such month. In no event shall the rate of interest chargeable hereunder be less than 1.3% per month. Principal shall be payable in twelve equal monthly installments of Eight Thousand Three Hundred Dollars ($8,300.00) commencing December 1, 1999 and continue thereafter on the 1st day of each month, plus interest shall be payable monthly commencing December 1, 1999 and continue thereafter on the 1st day of each month, and one final installment on May 21, 2000 equal to all principal outstanding together with all accrued and unpaid interest. This note is secured by that certain Loan and Security Agreement ("Agreement") dated October 29, 1999 and is subject to all of the terms and conditions thereof. In the event of default under the Agreement, including but not limited to, the failure to pay any installment of principal or interest hereunder when due, the holder of this note may, at its election and without notice to the undersigned, declare the entire balance hereof immediately due and payable. If any installment of principal or interest hereunder is not paid when due, the holder shall have the following rights in addition to the rights set forth in the preceding paragraph: (a) the right to add unpaid interest to principal and to have such amount thereafter bear interest as provided in this note, and (b) if any installment is more than ten days past due, the right to collect a charge equal to the greater of $15.00 or five percent of the delinquent payment. This charge is the result of a reasonable endeavor by the undersigned and the holder to estimate the holder's added costs and damages resulting from the undersigned's failure to timely make payments under this note; hence the undersigned agrees that the charge shall be presumed to be the amount of damage sustained by the holder since it is extremely difficult to determine the actual amount necessary to reimburse the holder of such damages. If this note is not paid when due, the undersigned further promises to pay all costs of collection, foreclosure fees and reasonable attorneys' fees incurred by the holder whether or not suit is filed hereon. Provided the undersigned is not then in default hereunder or under any other agreement with the holder of this note, this note may be prepaid at any time prior to one year from the date hereof by paying the balance of principal owing plus all accrued and unpaid interest and charges, together with a prepayment charge of N/A on the amount prepaid. Presentment for payment, notice of dishonor, protest, and notice of protest are expressly waived. This note cannot be changed, modified, amended or terminated orally. WAIVER OF TRIAL BY JURY. THE UNDERSIGNED, TO THE EXTENT IT MAY LEGALLY DO SO, HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING ARISING UNDER OR WITH RESPECT TO THIS NOTE, OR IN ANY WAY CONNECTED WITH, OR RELATED TO, OR INCIDENTAL TO, THE DEALINGS OF THE PARTIES HERETO WITH RESPECT TO THIS NOTE OR THE TRANSACTIONS RELATED THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND IRRESPECTIVE OF WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. THE UNDERSIGNED, TO THE EXTENT IT MAY LEGALLY DO SO, HEREBY AGREES THAT ANY SUCH CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING SHALL BE DECIDED BY A COURT TRIAL WITHOUT A JURY AND THAT THE HOLDER OF THIS NOTE MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE UNDERSIGNED TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. IN WITNESS WHEREOF, this Note has been executed and delivered on the date first set forth above. LEE PHARMACEUTICALS a California corporation By: /s/ Ronald G. Lee ------------------------ Ronald G. Lee, President EX-27 6 EXHIBIT 27
5 3-MOS SEP-30-2000 OCT-01-1999 DEC-31-1999 6 0 1,145 (157) 2,407 4,014 6,709 6,211 8,134 6,748 0 0 0 413 (3,036) 8,134 2,322 2,537 1,068 2,321 0 0 216 18 0 18 0 0 0 18 .00 .00
-----END PRIVACY-ENHANCED MESSAGE-----